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THE	  EFFICACY	  OF	  MINDFULNESS	  AS	  A	  
COMPLEMENTARY	  CANCER	  THERAPY	  
PATRICK	  DONAN	  JOYCE	  ABSTRACT	  Cancer	  is	  a	  life-­‐changing	  disease	  that	  introduces	  an	  abundance	  of	  psychosocial	  stress	  into	  patient’s	  lives.	  	  Exposure	  to	  psychosocial	  stress	  over	  periods	  of	  weeks	  or	  more	  has	  a	  maladaptive	  effect	  on	  the	  human	  immune	  system.	  	  Chronic	  psychosocial	  stress	  means	  elevated	  activates	  the	  hypothalamic-­‐pituitary-­‐adrenal	  (HPA)	  and	  the	  sympathetic-­‐adrenomedullary	  (SAM)	  axes	  which	  over	  time	  induce	  deleterious	  physiological	  effects	  in	  the	  form	  of	  glucocorticoid	  resistance,	  chronic	  low-­‐level	  inflammation,	  and	  inhibition	  of	  leukocyte	  telomerase	  activity.	  Because	  these	  down-­‐stream	  physiologic	  effects	  of	  psychosocial	  stress	  have	  oncogenic	  implications,	  the	  effective	  management	  of	  chronic	  stress	  inherent	  to	  a	  cancer	  diagnosis	  should	  positively	  impact	  the	  efficacy	  of	  current	  cancer	  therapies.	  	  	  Mindfulness	  is	  an	  age-­‐old	  concept	  that	  has	  recently	  gained	  traction	  in	  the	  medical	  community	  for	  its	  utility	  as	  a	  cognitive	  therapy	  in	  treating	  patients	  with	  mental	  health	  disorders.	  	  Although	  the	  study	  of	  mindfulness	  as	  a	  complementary	  cancer	  therapy	  is	  in	  its	  relative	  infancy,	  other	  examples	  of	  mind-­‐body	  medicine	  have	  already	  been	  documented	  to	  help	  treat	  many	  psychological	  side	  effects	  of	  cancer	  including	  anxiety,	  depression,	  sleep	  deprivation,	  and	  pain.	  It	  has	  been	  theorized	  that	  mindfulness	  acts	  by	  providing	  a	  cognitive	  strategy	  to	  buffer	  the	  harmful	  effects	  of	  psychosocial	  stress.	  	  	  
	  	   vi	  
Mindfulness	  elicits	  discrete	  effects	  on	  human	  psychology	  and	  physiology	  that	  are	  conducive	  to	  the	  efficacy	  of	  current	  cancer	  treatments.	  Mindfulness	  techniques	  have	  shown	  promise	  in	  providing	  relief	  for	  many	  of	  the	  psychological	  side	  effects	  of	  a	  cancer	  diagnosis.	  In	  this	  thesis,	  we	  explore	  the	  psychological	  and	  physiological	  effects	  of	  mindfulness	  practice	  that	  counter-­‐act	  many	  of	  the	  harmful	  consequences	  of	  chronic	  stress	  exposure	  specifically	  immunosuppression,	  chronic	  inflammation,	  and	  telomerase	  activity.	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INTRODUCTION	  	   Cancer	  was	  the	  second	  most	  common	  cause	  of	  death	  in	  the	  United	  States	  in	  2014.	  It	  claimed	  the	  lives	  of	  over	  585,000	  Americans	  (American	  Cancer	  Society,	  2014).	  There	  are	  14.5	  million	  survivors	  living	  in	  the	  United	  States,	  with	  1.6	  million	  of	  those	  newly	  diagnosed	  in	  2014.	  (American	  Association	  for	  Cancer	  Research,	  2014).	  According	  to	  the	  National	  Institute	  of	  Health	  $86.6	  billion	  dollars	  were	  spent	  on	  direct	  medical	  costs	  related	  to	  cancer	  (American	  Cancer	  Society,	  2014).	  A	  cancer	  diagnosis,	  and	  subsequent	  treatment,	  results	  in	  a	  host	  of	  debilitating	  stress-­‐related	  symptoms	  separate	  from	  the	  pathogenesis	  of	  the	  tumor	  (Fan	  et	  al.,	  2007).	  On	  average,	  cancer	  patients	  experience	  between	  11-­‐13	  simultaneous	  symptoms	  during	  their	  treatment	  (Chang	  et	  al.,	  2000).	  The	  most	  common	  of	  these	  symptoms	  are	  pain,	  sleep	  deprivation,	  and	  depression:	  effective	  treatment	  of	  these	  so-­‐called	  psychosocial	  side	  effects	  has	  a	  strong	  influence	  on	  patients’	  quality	  of	  life	  (Compare,	  et	  al.,	  2014;	  Dodd	  et	  al.,	  2010).	  	  In	  fact,	  recent	  research	  has	  indicated	  that	  stress-­‐related	  psychosocial	  factors	  may	  be	  implicated	  in	  tumor	  development	  and	  progression	  Effective	  identification	  and	  treatment	  of	  these	  stress-­‐related	  symptoms	  have	  been	  shown	  to	  positively	  impact	  treatment	  outcomes	  (Chida	  et	  al.,	  2008).	  Understanding	  how	  chronic	  psychosocial	  stress	  alters	  human	  physiology	  and	  interacts	  with	  current	  cancer	  therapies	  may	  provide	  a	  means	  by	  which	  current	  cancer	  treatments	  can	  be	  improved.	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   In	  non-­‐oncological	  patient	  populations	  both	  pharmacological	  and	  psychosocial	  therapies	  are	  utilized	  to	  treat	  those	  suffering	  from	  these	  psychosocial	  stress-­‐related	  conditions.	  Studies	  exploring	  the	  effect	  of	  psychosocial	  stress	  on	  cardiovascular	  health	  established	  a	  ‘lack	  of	  a	  social	  support	  network’	  as	  a	  risk	  factor	  in	  coronary	  heart	  disease	  (Compare,	  et	  al.,	  2013).	  Another	  example	  is	  anxiety	  and	  depression’s	  association	  with	  immunosuppression	  (Morgan	  et	  al.,	  2014).	  Scientists	  have	  applied	  this	  knowledge	  to	  counter-­‐act	  the	  deleterious	  physiologic	  effects	  of	  chronic	  stress	  by	  developing	  cognitive	  therapies	  that	  elicit	  the	  relaxation	  response	  (Mayden,	  2012).	  Despite	  attempts	  to	  study	  the	  efficacy	  of	  these	  interventions	  in	  cancer	  patients	  with	  depression,	  there	  is	  no	  consensus	  on	  which	  treatment	  regimens	  are	  most	  effective	  (Rodin	  et	  al.,	  2007).	  	  In	  the	  last	  decade	  there	  has	  been	  a	  push	  to	  understand	  the	  efficacy	  of	  complementary	  and	  alternative	  medicine	  (CAM)	  treating	  the	  psychosocial	  stress-­‐related	  symptoms	  of	  cancer	  treatment.	  One	  CAM	  that	  has	  gained	  traction	  is	  the	  practice	  of	  mind-­‐body	  medicine	  (MBM).	  	  MBM	  focuses	  on	  the	  physiological	  relationship	  between	  mental	  states	  and	  overall	  health.	  	  It	  seeks	  to	  understand	  the	  physical	  manifestations	  of	  psychological	  disease	  (Mayden,	  2012).	  	  Mindfulness	  Based	  Stress	  Reduction	  (MBSR)	  was	  developed	  by	  Dr.	  John	  Kabat-­‐Zinn	  to	  adapt	  the	  ancient	  Eastern	  tradition	  of	  mindfulness	  to	  a	  clinical	  setting	  (Mayden	  2012).	  	  It	  consists	  of	  a	  combination	  of	  meditation,	  yoga,	  and	  other	  activities	  aimed	  at	  cultivating	  a	  state	  mindful	  consciousness,	  or	  non-­‐judgmental	  awareness	  within	  the	  practitioner	  (Brown	  &	  Ryan,	  2003).	  	  MBSR	  is	  designed	  to	  engage	  the	  innate	  ability	  to	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be	  aware	  of	  and	  pay	  attention	  to	  one’s	  own	  moment-­‐to-­‐moment	  conscious	  experience.	  	  The	  practice	  of	  mindfulness	  teaches	  a	  practitioner	  the	  ability	  to	  non-­‐judgmentally	  observe	  his	  or	  her	  own	  thoughts,	  emotions,	  and	  sensations	  (Holzel	  et	  al.,	  2011).	  Eight-­‐week	  regimens	  of	  MBSR	  have	  been	  shown	  to	  reduce	  stress,	  anxiety,	  and	  depression	  and	  be	  effective	  in	  treating	  treat	  a	  wide	  range	  of	  diseases	  ranging	  from	  obesity	  to	  drug	  addiction	  (Adams	  et	  al.,	  2014;	  Fjorback	  et	  al.,	  2011;	  O’Reilly	  et	  al.,	  2014).	  	  One	  of	  the	  most	  intriguing	  clinical	  applications	  of	  MBSR	  is	  as	  a	  complementary	  cancer	  therapy.	  	  The	  concept	  of	  buffering	  chronic	  stress	  is	  of	  special	  interest	  to	  cancer	  treatment,	  due	  to	  the	  synergistic	  effects	  of	  reducing	  side-­‐effects	  while	  potential	  enhancing	  the	  efficacy	  of	  current	  cancer	  therapies	  via	  physiologic	  changes.	  	  The	  goals	  of	  this	  thesis	  are	  to	  1)	  explore	  the	  potential	  mechanisms	  through	  which	  mindfulness	  meditation	  reduces	  psychosocial	  risk	  factors	  associated	  with	  cancer;	  and	  2)	  to	  review	  the	  evidence	  supporting	  mindfulness’s	  ability	  to	  improve	  quality	  of	  life	  and	  overall	  prognosis	  in	  cancer	  patients.	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PUBLISHED	  STUDIES	  	  	  
What	  is	  Mindfulness?	  	  	   Mindfulness	  is	  a	  tradition	  that	  has	  been	  passed	  down	  for	  thousands	  of	  years,	  but	  the	  psychological	  and	  physiological	  mechanisms	  responsible	  for	  its	  reported	  health	  benefits	  are	  incompletely	  understood.	  Mindfulness	  cultivates	  a	  mental	  state	  of	  attention	  to,	  and	  awareness	  of	  one’s	  consciousness	  in	  the	  present	  moment	  (Holzel	  et	  al.,	  2011).	  This	  state	  is	  achieved	  through	  practice	  of	  the	  two	  divisions	  of	  mindfulness,	  focused	  attention	  (FA)	  meditation	  and	  open	  monitoring	  meditation	  (OM)	  (Lutz	  et	  al,	  	  2009).	  	  FA	  meditation	  involves	  centering	  one’s	  complete	  focus	  on	  an	  individual	  stimulus.	  	  Extended	  FA	  practice	  leads	  to	  OM	  meditation,	  which	  involves	  expanding	  focus	  to	  every	  sensation	  present	  in	  consciousness	  at	  any	  given	  moment.	  The	  combined	  practice	  of	  these	  two	  forms	  of	  mindfulness	  meditation	  elicits	  a	  physiological	  relaxation	  response	  that	  then	  translates	  to	  health	  benefits	  (Lazar	  et	  al.,	  2000).	  	  FA	  meditation	  requires	  the	  practitioner	  to	  concentrate	  on	  a	  single	  sensation	  for	  an	  extended	  period	  of	  time,	  most	  often	  the	  rise	  and	  fall	  of	  one’s	  own	  breath.	  During	  meditation	  attention	  will	  naturally	  stray	  to	  thoughts,	  emotions,	  and	  sensations.	  It	  is	  the	  goal	  of	  FA	  practice	  to	  acknowledge	  each	  of	  these	  distractions	  as	  they	  arise,	  and	  then	  to	  return	  attention	  to	  the	  initial	  point	  of	  focus.	  This	  is	  the	  first	  step	  in	  non-­‐judgmentally	  observing	  one’s	  consciousness.	  	  FA	  practice	  calms	  the	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mind	  as	  a	  necessary	  precursor	  to	  OM	  meditation	  (Malinowski,	  2013;	  Marchand,	  2014).	  	  OM	  is	  a	  state	  of	  non-­‐judgmental	  monitoring	  of	  the	  practitioner’s	  full	  awareness.	  OM	  helps	  participants	  to	  monitor	  their	  own	  emotional	  trends	  and	  recognize	  and	  avoid	  unnecessary	  negative	  rumination	  and	  anxiety	  about	  future	  events	  (Zainal	  et	  al.,	  2013).	  	  Both	  FA	  and	  OM	  are	  powerful	  cognitive	  tools	  that	  give	  participants	  the	  ability	  to	  elicit	  the	  relaxation	  response.	  	  
Focused	  Attention	  (FA)	  	  Many	  of	  the	  brain	  regions	  activated	  by	  mindfulness	  practice	  have	  been	  previously	  described	  to	  be	  involved	  in	  the	  neural	  networks	  that	  facilitate	  attention.	  Attention	  regulation	  is	  accomplished	  through	  the	  coordination	  of	  the	  following	  neural	  networks:	  alerting	  network,	  orienting	  network,	  executive	  network,	  and	  the	  default	  mode	  network	  (Raz	  &	  Buhle,	  2006).	  	  The	  alerting	  network	  is	  employed	  to	  prime	  the	  brain	  in	  anticipation	  of	  a	  stimulus	  and	  the	  subsequent	  reaction	  to	  the	  stimulus.	  Imaging	  studies	  indicate	  this	  network	  consists	  of	  the	  thalamus,	  the	  right	  frontal	  cortex,	  and	  the	  right	  parietal	  cortex	  under	  the	  control	  of	  the	  anterior	  cingulate	  cortex	  (ACC)	  (Raz	  &	  Buhle,	  2006).	  The	  orienting	  attentional	  network	  allows	  the	  mind	  to	  focus	  attention	  on	  a	  single	  stimulus	  amongst	  a	  variety	  of	  stimuli.	  This	  network	  involves	  the	  pulvinar,	  superior	  parietal	  cortex,	  temporoparietal	  junction,	  and	  the	  superior	  temporal	  lobe	  (Posner	  &	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Rothbart,	  2007;	  Raz	  &	  Buhle,	  2006).	  The	  executive	  network	  is	  responsible	  for	  conflict	  monitoring.	  	  This	  mental	  process	  is	  what	  facilitates	  the	  ability	  to	  focus	  attention	  on	  a	  sensation	  or	  object	  and	  ignore	  distracting	  stimuli.	  The	  neuroanatomy	  of	  the	  executive	  network	  is	  less	  well	  understood,	  but	  evidence	  shows	  involvement	  of	  both	  the	  dorsal	  and	  rostral	  ACC,	  dorsolateral	  prefrontal	  cortex,	  and	  basal	  ganglia	  (Posner	  &	  Rothbart,	  2007;	  Raz	  &	  Buhle,	  2006).	  The	  default	  mode	  network	  is	  the	  dominant	  attentional	  network	  when	  attention	  is	  not	  focused	  on	  surrounding	  stimuli,	  or	  rather	  is	  engaged	  in	  stimulus-­‐independent	  thought	  (Hasenkamp	  et	  al.,	  2012).	  This	  network	  consists	  of	  the	  dorsal	  and	  ventral	  medial	  prefrontal	  cortex,	  posterior	  cingulate	  cortex	  and	  precuneus,	  posterior	  inferior	  parietal	  regions,	  lateral	  temporal	  cortex,	  and	  the	  hippocampus	  (Buckner	  et	  al.,	  2008).	  MBSR	  has	  been	  shown	  to	  increase	  activation	  in	  parietal	  regions	  associated	  with	  the	  alerting,	  orienting,	  and	  default	  mode	  networks	  (Goldin	  et	  al.,	  2013).	  	  	  Reviews	  by	  Marchand	  et	  al.	  and	  Holzel	  et	  al.	  both	  indicate	  the	  brain	  regions	  involved	  in	  the	  attentional	  networks	  play	  a	  critical	  role	  in	  mindfulness	  (Holzel	  et	  al.,	  2011;	  Marchand,	  2014).	  The	  practitioner	  begins	  utilizing	  their	  alerting	  and	  orienting	  network	  to	  focus	  attention	  on	  their	  sensation	  of	  choice.	  	  After	  an	  extended	  period	  of	  time,	  their	  mind	  will	  wander	  from	  this	  single	  point	  of	  attention.	  	  During	  this	  wandering	  the	  default	  mode	  network	  is	  engaged.	  Eventually,	  the	  executive	  network	  will	  help	  the	  practitioner	  recognize	  this	  lost	  train	  of	  thought,	  and	  return	  attention	  to	  the	  chosen	  stimulus	  (Hasenkamp	  et	  al.,	  2012;	  Malinowski,	  2013).	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Consistent	  FA	  practice	  helps	  to	  enhance	  attention.	  Self-­‐reported	  mindfulness	  and	  attentional	  performance	  are	  positively	  correlated.	  (Jha	  et	  al.,	  2007).	  	  Experienced	  FA	  meditators	  are	  able	  to	  sustain	  attention	  for	  prolonged	  periods	  of	  time	  when	  compared	  to	  non-­‐meditators	  (Carter	  et	  al.,	  2005;	  Chambers	  et	  al.,	  2007;	  Slagter	  et	  al.,	  2008).	  Interestingly	  attentional	  control	  is	  inversely	  related	  to	  the	  frequency	  of	  intrusive	  or	  uncontrollable	  thoughts	  that	  elicit	  the	  stress	  response	  (Moradi,	  2014).	  Mindfulness	  based	  interventions	  have	  been	  indicated	  as	  potential	  cognitive	  therapies	  to	  help	  alleviate	  these	  intrusive	  thoughts	  that	  lead	  to	  depression	  (Wilkinson-­‐tough	  et	  al.,	  2010).	  There	  is	  significant	  evidence	  that	  mindfulness	  imparts	  its	  health	  benefits	  in	  part	  through	  the	  attentional	  networks.	  	  	  	  	  
Open	  Monitoring	  (OM)	  	   While	  FA	  requires	  full	  attention	  to	  a	  single	  sensation	  in	  one’s	  body,	  OM	  disengages	  directed	  focus	  and	  instead	  applies	  the	  same	  mentality	  to	  every	  bodily	  sensation	  experienced	  by	  the	  practitioner	  in	  any	  given	  moment.	  	  Because	  OM	  discourages	  individually	  evaluating	  any	  single	  stimulus,	  it	  reduces	  the	  cognitive	  workload	  placed	  on	  the	  brain	  in	  any	  given	  moment	  (Slagter	  et	  al.,	  2007).	  This	  meditative	  practice	  provides	  insight	  to	  the	  intensity	  of	  each	  sensation	  and	  the	  emotional	  reaction	  elicited	  by	  the	  sensation	  within	  the	  practitioner	  (Lutz	  et	  al.,	  2009).	  It	  allows	  the	  practiced	  participant	  to	  more	  efficiently	  experience	  a	  stimulus	  without	  automatically	  emotionally	  reacting	  to	  it.	  The	  objective	  awareness	  gained	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though	  OM	  practice	  can	  be	  utilized	  to	  recognize	  and	  ignore	  adverse	  mental	  states	  such	  as	  anxiety	  or	  depression	  (Hatchard	  et	  al.,	  2014).	  This	  cognitive	  strategy	  helps	  the	  practitioner	  to	  non-­‐judgmentally	  confront	  emotional	  triggers	  (Bishop	  et	  al.,	  2006).	  	  It	  encourages	  practitioners	  to	  observe	  rather	  than	  be	  influenced	  by	  emotional	  states	  (Jain	  et	  al.,	  2007)	  	  OM	  meditation	  does	  not	  involve	  a	  specific	  attentional	  focus,	  and	  therefore	  evidence	  suggests	  that	  it	  does	  not	  utilize	  the	  same	  neural	  networks	  discussed	  in	  the	  previous	  section.	  	  Instead	  it	  employs	  regions	  of	  the	  brain	  dedicated	  to	  vigilance,	  monitoring,	  and	  disengagement	  of	  attention	  from	  single	  sensations	  (Lutz	  et	  al.,	  2009).	  Functional	  MRI	  evidence	  suggests	  that	  extensive	  practice	  of	  OM	  is	  associated	  with	  increased	  left	  hemisphere	  medial	  frontal	  activation,	  and	  lateral	  prefrontal	  activation	  in	  both	  the	  left	  and	  right	  hemispheres	  (Manna	  et	  al.,	  2010).	  Extensive	  OM	  meditative	  practice	  has	  been	  found	  to	  induce	  functional	  reorganization	  in	  the	  prefrontal	  cortex	  and	  the	  insula,	  potentially	  presenting	  a	  mechanism	  through	  which	  mindfulness’s	  cognitive	  benefits	  are	  sustained	  (Manna	  et	  al.,	  2010).	  
	  
Physiology	  of	  the	  Relaxation	  Response	  	   In	  1974,	  Herbert	  Benson	  coined	  the	  term	  ‘relaxation	  response’	  to	  describe	  the	  physiological	  state	  opposite	  of	  that	  induced	  by	  the	  stress	  response	  (Benson	  et	  al.,	  1974).	  Activation	  of	  the	  relaxation	  response	  results	  in	  reduced	  autonomic	  and	  psychological	  arousal	  leading	  to	  decreased	  heart	  rate,	  metabolic	  rate,	  respiratory	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rate,	  serum	  catecholamine	  concentrations,	  and	  serum	  glucocorticoid	  concentrations	  (Chang	  et	  al.,	  2011).	  It	  has	  been	  hypothesized	  that	  mindfulness	  elicits	  this	  response	  by	  modulating	  activity	  in	  the	  Hypothalamic-­‐Pituitary-­‐Adrenal	  (HPA)	  axis.	  Mindfulness	  is	  able	  to	  combat	  the	  harmful	  effect	  of	  chronic	  stress	  by	  giving	  the	  practitioner	  the	  mental	  tools	  to	  consciously	  stimulate	  the	  parasympathetic	  nervous	  system	  and	  elicit	  the	  relaxation	  response	  (Borysenko	  et	  al.,	  1985;	  Edenfield	  &	  Saeed,	  2012).	  	  Regular	  elicitation	  of	  the	  relaxation	  response	  decreases	  sympathetic	  nervous	  system	  activity	  during	  exposure	  to	  stress	  due	  to	  a	  decreased	  sensitivity	  to	  norepinephrine	  in	  target	  organs	  (Esch	  et	  al.,	  2003).	  	  	  Several	  studies	  have	  found	  mindfulness	  to	  induce	  a	  hypometabolic	  state	  consisting	  of	  reduced	  oxygen	  consumption,	  reduced	  carbon	  dioxide	  elimination,	  decreased	  arterial	  blood	  pH,	  and	  decreased	  blood	  lactate	  (Wallace	  et	  al.,	  1971).	  All	  of	  these	  physiological	  alterations	  are	  opposite	  of	  those	  elicited	  by	  stimulation	  of	  the	  HPA	  axis	  induced	  stress	  response.	  Gene	  expression	  analyses	  have	  confirmed	  the	  inverse	  activity	  of	  the	  relaxation	  response	  compared	  to	  the	  stress	  response	  (Dusek	  et	  al.,	  2008).	  	  Eight	  weeks	  of	  relaxation	  response	  training	  was	  found	  to	  down-­‐regulate	  expression	  of	  ubiquitin,	  proteasomes,	  ribosomal	  proteins,	  and	  stress	  response	  genes.	  	  In	  addition,	  there	  were	  alterations	  in	  expression	  of	  genes	  involved	  in	  apoptosis	  and	  immune	  function	  due	  to	  relaxation	  response	  practice	  (Dusek	  et	  al.,	  2008).	  	  If	  the	  relaxation	  response	  elicited	  through	  mindfulness	  is	  truly	  the	  ‘yin’	  to	  the	  stress	  response’s	  ‘yang’,	  then	  it	  would	  be	  reasonable	  to	  conclude	  relaxation	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sponsored	  by	  mindfulness	  may	  help	  buffer	  the	  deleterious	  effects	  of	  chronic	  activation	  of	  the	  stress	  response.	  	  	  
Physiology	  of	  the	  Stress	  Response	  	  	  In	  order	  to	  fully	  comprehend	  the	  potential	  clinical	  applications	  of	  mindfulness	  based	  therapies	  we	  must	  examine	  the	  physiology	  of	  the	  stress	  response	  and	  what	  cellular	  consequences	  arise	  due	  to	  exposure	  to	  chronic	  stress.	  Psychosocial	  stress	  refers	  to	  any	  variety	  of	  potential	  stimuli	  that	  evokes	  the	  body’s	  natural	  fight	  or	  flight	  response.	  This	  response	  is	  mediated	  through	  activation	  of	  the	  sympathetic	  autonomic	  nervous	  system	  resulting	  in	  up-­‐regulation	  of	  the	  sympathetic-­‐adrenomedullary	  (SAM)	  axis	  and	  the	  hypothalamic-­‐pituitary-­‐adrenal	  axis	  (HPA)	  (Jansen	  et	  al.,	  1995;	  Pignatelli,	  Magalhâes	  &	  Magalhães,	  1998)	  	  	  
The	  sympathetic-­‐adrenomedullary	  axis	  	  The	  SAM	  axis	  is	  designed	  to	  cope	  with	  acute	  stressors.	  	  It	  consists	  of	  chromaffin	  cells	  residing	  in	  the	  adrenal	  medulla	  that	  are	  stimulated	  by	  sympathetic	  cholinergic	  preganglionic	  neurons	  to	  release	  the	  catecholamines,	  epinephrine	  and	  norepinephrine	  (Gunnar	  &	  Quevedo,	  2007).	  When	  released	  into	  the	  systematic	  circulation	  catecholamines	  induce	  an	  increase	  cardiac	  output,	  redirect	  blood	  flow	  to	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the	  brain	  and	  muscles,	  produce	  a	  sharp	  rise	  in	  serum	  glucose	  levels,	  and	  activate	  the	  HPA	  axis	  (Gunnar	  &	  Quevedo,	  2007).	  	  	  	  
The	  hypothalamic-­‐pituitary-­‐adrenal	  axis	  	  	  Hypothalamic	  and	  pituitary	  endocrine	  signaling	  stimulate	  the	  HPA	  axis	  causing	  the	  production	  of	  glucocorticoids	  by	  the	  adrenal	  cortex,	  (Figure	  1;	  Lightman	  &	  Conway-­‐Campbell,	  2010).	  In	  response	  to	  stressful	  stimuli,	  the	  paraventricular	  nucleus	  of	  the	  hypothalamus	  releases	  corticotropin-­‐releasing	  factor	  (CRF)	  into	  the	  hypophysial	  portal	  veins	  leading	  to	  the	  anterior	  lobe	  of	  the	  pituitary	  gland	  (Herman	  et	  al.,	  2003).	  Binding	  of	  CRF	  to	  pituitary	  corticotropic	  cells	  causes	  the	  secretion	  of	  adrenocorticotropic	  hormone	  (ACTH)	  into	  systemic	  circulation.	  	  ACTH	  travels	  to	  the	  cortex	  of	  the	  adrenal	  gland	  where	  it	  initiates	  glucocorticoid	  synthesis	  and	  release	  (Gunnar	  &	  Quevedo,	  2007).	  	  Glucocorticoids	  travel	  through	  the	  blood	  stream,	  and	  enter	  the	  cytoplasm	  of	  target	  cells	  where	  they	  bind	  the	  glucocorticoid	  receptor	  (GR).	  Binding	  of	  the	  ligand	  to	  the	  receptor	  induces	  a	  conformational	  change	  in	  the	  GR	  that	  results	  in	  translocation	  to	  the	  nucleus	  (Kadmiel	  &	  Cidlowski,	  2013).	  Once	  in	  the	  nucleus	  GR	  binds	  genomic	  response	  elements,	  activating	  anti-­‐inflammatory	  genomic	  programs	  and	  down	  regulating	  the	  transcription	  of	  mRNAs	  involved	  in	  the	  immune	  response.	  	  In	  fact,	  glucocorticoids	  play	  a	  critical	  role	  in	  the	  termination	  of	  immune	  inflammatory	  responses	  (Stark	  et	  al.,	  2001).	  In	  addition,	  GR	  regulation	  causes	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antiproliferative,	  antiangiogenic,	  and	  proapoptotic	  alterations	  in	  gene	  expression	  programs	  (Zen	  et	  al.,	  2011).	  	  
	  Figure	  1.	  The	  hypothalamic-­‐pituitary-­‐adrenal	  axis.	  This	  figure	  illustrates	  the	  anatomy	  and	  physiology	  of	  the	  HPA	  axis	  stress	  response.	  	  Under	  control	  of	  the	  central	  nervous	  system	  the	  paraventricular	  nucleus	  of	  the	  hypothalamus	  releases	  corticotropin-­‐releasing	  hormone	  and	  arginine	  vasopressin	  into	  the	  portal	  vein	  to	  stimulate	  anterior	  pituitary	  adrenocorticotropic	  hormone	  production.	  	  The	  anterior	  pituitary	  then	  releases	  ACTH	  into	  systemic	  circulation	  where	  it	  stimulates	  the	  adrenal	  cortex	  to	  produce	  and	  release	  cortisol	  into	  systemic	  circulation	  (Lightman	  &	  Conway-­‐Campbell,	  2010)	  	  
	  



















property of the interaction between the  
pituitary and adrenal glands that can  
produce ultradian rhythmicity.
Engineers and mathematicians have 
known for many years that delays in feed-
forward and feedback circuitry can result 
in system malfunction and oscillation. For 
example, even during the First World War 
it was known that the delay in feedback 
to gunnery systems that was caused by 
the slow rate of movement of a gun turret 
resulted in oscillatory activity of the tur-
ret23. This raised the question as to whether 
biological systems such as the HPA axis are 
subject to similar mechanisms.
A fascinating aspect of the pituitary–
adrenal system is the positive, delayed, feed-
forward connection between the pituitary 
and the adrenals24 and the negative feedback 
of glucocorticoids on ACTH release25. The 
delay in feedforward circuitry is illustrated 
in the 24-hour ACTH and cortisol rhythm 
(FIG. 1d), which shows that in humans every 
secretory episode of ACTH is followed by a 
delayed response of cortisol26. In addition, 
glucocorticoids exert a rapid inhibitory 
effect on ACTH secretion27. Based on this 
knowledge, we used the technique of  
numerical continuation to derive a theoreti-
cal model describing natural oscillatory 
rhythms in the HPA axis28. This model sup-
ports the concept that simple feedforward 
and feedback interactions between the 
pituitary and adrenal cortex can account 
for the glucocorticoid rhythms that have 
been observed experimentally. This model 
explains not only the change in pulse ampli-
tude based on changing levels of the ACTH-
stimulating peptides CRH and arginine 
vasopressin in the hypothamus–pituitary 
portal blood, but also the loss of pulsatile 
secretion that occurs both at the nadir of 
HPA axis activity and following an acute 
stress response29 (BOX 1). Non-ACTH inputs 
to the adrenals, such as the splanchnic 
nerve30, and intra-adrenal clock mecha-
nisms31 could also modulate the pattern of 
this pituitary–adrenal oscillation by altering 
adrenal sensitivity to ACTH.
CBG modulation of gluco corticoid  
bio-availability. A recent study has shed 
light on a major regulatory determinant of 
free-cortisol pulses in terms of whole-body 
physiology32. Approximately 95% of 
circulating glucocorticoid is bound to carrier 
proteins and is therefore not bio-available to 
target cells. The major glucocorticoid carrier 
protein is CBG, a member of the serpin fam-
ily of proteins. These proteins undergo con-
formational change on binding and releasing 
hormones. CBG is saturated at 400–500 nmol 
per l cortisol33, and plasma cortisol levels 
above this concentration (that is, at the peak 
concentrations of each pulse) increase the 
percentage of free cortisol that is available 
for diffusion across cell membranes32. The 
effect of glucocorticoids on the target tissues 
is therefore related to this more pronounced 
pulsatile profile of free bio-available steroid,  
rather than to the level of total cortisol 
measured in circulating blood. This has 
physiological importance as the free form of 
glucocorticoid is crucial for the consequent 
signalling response. Furthermore, CBG acts 
as a thermocouple, showing a markedly 
reduced affinity for glucocorticoids when 
body temperature increases during a fever. 
This has clear clinical relevance, as fever or 
application of external heat will result in 
higher amplitude pulses at target tissues.
The role of pulses in HPA axis responses  
to stress. It is generally assumed that gluco-
corticoids are secreted either tonically, 
with variation only related to the circadian 
cycle, or in a phasic manner in response to 
a stressor. However, functional interactions 
between glucocorticoid pulsatility and the 
stress response have been known for more 
than a decade. A recent study assessed the 
stress-responsiveness of rats during differ-
ent phases of their ultradian corticosterone 
secretory profile29. The rats displayed a 
considerably greater HPA axis responsive-
ness when a 99-dB noise stress was applied 
during the rising phase of a corticosterone 
pulse than when stress was applied during 
the falling phase, suggesting a facilitated 
stress response during the rising phase and/
or an inhibitory effect during the falling 
phase (FIG. 2a). This raised the question of 
whether the pulses of corticosterone medi-
ate the differences in the stress responses 
over these short time intervals, or whether 
they are merely coincident. A recent study 
has addressed this question by using a 
computer-controlled automated infusion 
system (see Supplementary information S1 
(figure)), which combines corticosterone 
infusion with high-frequency automated 
blood sampling in freely behaving rats in 
their home cages34. This study revealed that, 
even when the pulses of corticosterone were 
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Effects	  of	  chronic	  HPA	  and	  SAM	  axes	  activation	  	  These	  two	  divisions	  of	  the	  stress	  response	  mediate	  the	  release	  of	  signaling	  molecules	  systematically	  to	  reach	  nearly	  every	  cell	  in	  the	  body.	  Temporary	  stimulation	  of	  sympathetic	  signaling	  is	  necessary	  for	  survival,	  but	  extended	  activation	  of	  this	  system	  can	  have	  deleterious	  consequences	  (Gunnar	  &	  Quevedo,	  2007).	  Due	  to	  the	  global	  effect	  of	  the	  stress	  response,	  activation	  lasting	  for	  multiple	  hours	  per	  day	  for	  weeks	  or	  more	  can	  have	  maladaptive	  metabolic	  and	  genomic	  effects	  on	  cells	  throughout	  the	  body	  (Chrousos	  &	  Kino,	  2007).	  Table	  1	  lists	  the	  alterations	  in	  neural	  activity	  in	  specific	  brain	  regions	  that	  are	  caused	  by	  chronic	  stress	  exposure	  (Table	  1;	  Ulrich-­‐Lai	  &	  Herman,	  2009).	  	   Table	  1.	  Chronic	  stress-­‐induced	  alternations	  in	  neurophysiology	  adapted	  from	  Ulrich-­‐Lai	  and	  Herman,	  2009	  
	  	  
Glutamic acid decarboxylase
(GAD). The enzyme that 
synthesizes GABA. It exists in 
two isoforms, GAD65 and 
GAD67.
GABAergic projections)88. The net output from the arcu-
ate to the PVN is complex, communicating both orexi-
genic (neuropeptide Y and Agouti-related peptide) and 
anorexic (for example, α-melanocyte-stimulating hor-
mone)88 signals. Notably, many of these peptides activate 
the HPA axis, implying that both positive and negative 
energy balance represent homeostatic stressors89.
Lateral hypothalamic neurons are activated by stres-
sors40 and thus are positioned to modulate autonomic 
and/or HPA tone. The lateral hypothalamus is targeted by 
hippocampal, prefrontal cortical and amygdalar efferents 
and is important in coordinating ingestive behaviours86. 
Glutamatergic, GABAergic and peptidergic neurons are 
highly intermingled in this region, making it difficult to 
predict its net impact on stress responses90,91.
The suprachiasmatic nucleus (SCN) has a substan-
tial impact on basal HPA and autonomic tone and on 
responses to psychogenic stressors92–94. The SCN has 
few direct projections to the PVN but heavily innervates 
the area surrounding the PVN95, where it can interface 
with input from limbic sites. The SCN is the primary 
coordinator of physiological rhythms and is thus posi-
tioned to modulate HPA axis output in conjunction with 
time-of-day cues.
Neural control of chronic-str ss responses
Chronic stress exposure physically alters the structure 
and function of brain regions involved in controlling HPA 
and autonomic responses to stress (TABLE 1). In the hip-
pocampus and prefrontal cortex, chronic restraint causes 
retra ion of apical dendrites and reduc s spine density 
in pyramidal cells96,97. Conversely, increased dendritic 
branching is observed in the BLA98. Chronic stress also 
induces changes in the PVN, including increased expres-
sion of CRH and vasopressin mRNA99,100, reduced GR 
expres ion99,100 and altered expression of numerous neuro-
transmitter receptor subunits101,102. Finally, neurochemical 
changes are seen in numerous stress regulatory pathways 
that project to the PVN, including increased glutamic acid 
decarboxylase expression (implying increased GABA 
levels) in the hypothalamus and the BST103.
Sensitization of stress responses. Neurochemical evi-
dence suggests that chronic stress enhances the excit-
ability of the HPA and the sympatho-adrenomedullary 
systems. Facilitated ACTH and corticosterone responses 
to novel stressors occur after chronic drive by either 
homotypical or unpredictable stress regimens104,105. This 
response facilitation occurs despite clear evidence for 
ongoing or cumulative elevation in glucocorticoid lev-
els, implying that feedback efficacy is diminished and/or 
drive is increased.
Chronic stress can recruit pathways that are distinct 
from those involved in acute responses. For example, 
lesions of the paraventricular thalamus inhibit the 
development of chronic-stress-induced facilitation of 
HPA axis activation but do not affect responses to acute 
stress106, indicating that this region is engaged during 
repeated chronic stress exposure. By contrast, lesions 
of the hippocampus do not affect HPA axis responses 
associated with chronic stress47, suggesting that its role 
in HPA axis regulation is diminished by repeated stress 
exposure. The BST seems to be differentially involved 
in acute- and chronic-stress respo ses, as lesions of the 
anterolateral BST reduce HPA axis responses to acute 
stress but enhance chronic-stress-induced facilitation of 
HPA axis activation107.
Repeated exposure to cold enhances stress-induced 
n radrenaline release in the frontal cortex and sensitizes 
the firing rate of locus coeruleus neurons following a 
novel stressor108–110. Chronic cold stress also increases 
the sensitivity of the locus coeruleus to CRH, suggest-
ing that such stress increases the responsiveness to a 
f ctor that is released during stress109. Finally, chronic 
stress increases the expression of tyrosine hydroxylase, 
the rate-limiting enzyme in noradrenaline synthesis, in 
Table 1 | Neuroplastic responses to chronic stress
Site Chronic-stress-induced plasticity Effect
Hippocampus Dendritic atrophy and decreased GR 
expression
Decreased HPA feedback and decreased 
memory
Medial prefrontal cortex Dendritic atrophy and decreased GR 
expression
Decreased HPA feedback, decreased memory 
extinction and decreased reward
Central amygdala Increased CRH expression and release Increased HPA and autonomic excitability, and 
anxiety
Basolateral amygdala Increased dendritic branching and 
increased stress excitability
Increased HPA and autonomic excitability, 




Increased stress excitability Increased HPA excitability to novel stress and 
decreased HPA excitability to familiar stress
Locus coeruleus Increased neurotransmitter release and 
increased stress excitability of projections 
to the cortex and hippocampus
Increased HPA excitability to novel stress
Paraventricular nucleus 
of the hypothalamus
Increased secretagogue synthesis, 
increased stress responsiveness and 
decreased GR expression
Increased excitability to novel stress
CRH, corticotropin-releasing hormone; GR, glucocorticoid receptor; HPA, hypothalamic-pituitary-adrenocortical; mPFC, medial 
prefrontal cortex. 
REVIEWS
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Chronic	  stress	  has	  been	  associated	  with	  fatigue,	  mental	  health	  disorders,	  coronary	  heart	  disease,	  diabetes,	  obesity,	  and	  cancer	  among	  other	  health	  conditions	  (Abbott	  et	  al.,	  2014;	  Compare	  et	  al.,	  2014;	  ;	  Chida	  et	  al.,	  2008;	  Räikkönen	  et	  al.,	  1996).	  The	  harmful	  effects	  of	  chronic	  stress	  are	  mediated	  primarily	  through	  immunosuppression	  and	  glucocorticoid	  resistance	  resulting	  in	  chronic	  low-­‐level	  peripheral	  inflammation	  (Dhabhar,	  2014;	  Kiecolt-­‐glaser	  et	  al.,	  2003;	  Rohleder,	  2014).	  In	  addition,	  chronic	  stress	  further	  affects	  immune	  function	  by	  leading	  to	  maladaptive	  behaviors	  such	  as	  poor	  sleep	  habits	  and	  drug	  abuse	  (R.	  Glaser	  &	  Kiecolt-­‐glaser,	  2005).	  	  	  	  	  
	  
Chronic	  Stress	  and	  Immune	  Dysregulation	  	  	   One	  of	  the	  most	  prominent	  paradoxes	  of	  the	  mammalian	  stress	  response	  is	  the	  contrasting	  effect	  of	  acute	  stress	  and	  chronic	  stress	  on	  the	  viability	  of	  immune	  function.	  	  Short-­‐term	  acute	  psychosocial	  stressors	  enhance	  immune	  function	  by	  inducing	  a	  redistribution	  of	  leukocytes	  from	  the	  spleen	  and	  other	  organs	  to	  the	  skin,	  gastrointestinal	  tract,	  urinogenital	  tract,	  lungs,	  liver,	  and	  lymph	  nodes	  (Dhabhar,	  et	  al.,	  2012).	  	  This	  action	  is	  coordinated	  by	  stimulation	  of	  the	  HPA	  axis	  and	  release	  of	  glucocorticoid	  and	  catecholamine	  into	  the	  blood	  (Rosenberger	  et	  al.,	  2009).	  	  In	  addition,	  acute	  stress	  at	  the	  time	  of	  primary	  antigen	  exposure	  increases	  the	  immune	  response	  to	  subsequent	  future	  re-­‐exposure	  to	  the	  same	  antigen	  (Dhabhar	  &	  Viswanathan,	  2005).	  Acute	  stress	  exposure	  has	  even	  been	  found	  to	  enhance	  the	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body’s	  ability	  to	  effectively	  eliminate	  immune	  responsive	  tumors	  (Kripke,	  1994).	  	  	  A	  healthy	  immune	  system	  is	  a	  critical	  tool	  in	  the	  fight	  against	  cancer.	  Part	  of	  its	  responsibility	  is	  to	  act	  as	  tumor	  surveillance	  (Reiche	  et	  al.,	  2004).	  The	  immune	  system	  can	  identify	  and	  eliminate	  specific	  tumor	  cells	  based	  on	  their	  expression	  of	  tumor	  cell	  antigens,	  a	  process	  known	  as	  immunoediting	  (Dunn	  et	  al.,	  2002).	  In	  addition,	  the	  immune	  system	  executes	  an	  interferon	  response	  to	  help	  suppress	  oncogenic	  viruses	  such	  as	  human	  papillomaviruses	  and	  the	  Epstein-­‐Barr	  virus	  (American	  Cancer	  Society,	  2014)	  (Goodbourn,	  2000).	  	  Finally,	  a	  healthy	  immune	  system	  must	  be	  able	  to	  induce	  inflammation	  to	  respond	  to	  a	  pathogen,	  and	  quickly	  resolve	  the	  inflammation	  to	  prevent	  creating	  a	  chronic	  tumorigenic	  environment.	  	  When	  the	  acute	  stress	  response	  becomes	  chronic,	  native	  immune	  function	  becomes	  dysregulated	  (Vitlic	  et	  al.,	  2014).	  Chronic	  stress	  inhibits	  leukocyte	  redistribution	  after	  exposure	  to	  an	  antigen,	  and	  reduces	  cell-­‐mediated	  immunity,	  antibody	  mediated	  immunity,	  natural	  killer	  cell	  activity,	  T	  cell	  activity,	  and	  macrophage	  activity	  (Dhabhar	  &	  Mcewen,	  1997;	  Dhabhar,	  2014).	  Accordingly,	  chronic	  stress	  has	  been	  linked	  to	  the	  development	  and	  progression	  of	  immune	  responsive	  tumors	  due	  to	  the	  suppression	  of	  type	  1	  cytokines,	  reduced	  numbers	  of	  CD4+	  and	  CD8+	  T	  cells	  at	  the	  tumor	  site,	  and	  increased	  numbers	  of	  regulatory	  T	  cells	  (Saul	  et	  al.,	  2005).	  	   Studies	  analyzing	  gene	  expression	  profiles	  of	  leukocytes	  in	  subjects	  who	  were	  self-­‐reportedly	  isolated	  from	  social	  contact	  have	  found	  increased	  expression	  of	  pro-­‐inflammatory	  genes	  and	  down-­‐regulation	  of	  glucocorticoid	  receptor	  and	  genes	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involved	  in	  immunoglobulin	  G,	  the	  most	  common	  antibody	  found	  in	  circulation,	  and	  interferon	  antiviral	  responses	  (Cole	  et	  al.,	  2007;	  Cole,	  et	  al.,	  2011).	  These	  transcriptional	  alternations	  are	  likely	  induced	  by	  NF-­‐kB	  pro-­‐inflammatory	  pathways,	  and	  are	  mediated	  through	  the	  initiation	  of	  glucocorticoid	  resistance,	  which	  will	  be	  discussed	  in	  the	  following	  section	  (figure	  2;	  Cole	  et	  al.,	  2007;	  Miller	  et	  al.,	  2009).	  It	  is	  important	  to	  note	  that	  these	  alternations	  in	  gene	  expression	  are	  due	  to	  perceived	  psychosocial	  stress,	  and	  are	  not	  correlated	  to	  objective	  measurements	  of	  stress.	  	  This	  fact	  indicates	  that	  by	  changing	  one’s	  perception	  of	  stress,	  it	  is	  possible	  to	  modulate	  the	  immune	  response	  without	  altering	  the	  objective	  stress	  to	  which	  an	  individual	  is	  exposed.	  	  	  	  
	  Figure	  2.	  The	  effect	  of	  social	  isolation	  on	  NF-­‐kB	  and	  glucocorticoid	  receptor	  transcription.	  Social	  isolation	  up-­‐regulates	  the	  pro-­‐inflammatory	  transcription	  factor	  NF-­‐kB,	  while	  concurrently	  down-­‐regulating	  the	  anti-­‐inflammatory	  action	  of	  the	  glucocorticoid	  receptor.	  	  Available	  promoter	  transcription	  factor	  binding	  sites	  is	  a	  measure	  of	  availability	  for	  gene	  transcription.	  	  Adapted	  from	  Cole	  et	  al.,	  2007	  
R189.6 Genome Biology 2007,     Volume 8, Issue 9, Article R189       Cole et al. http://genomebiology.com/2007/8/9/R189
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results are consistent with a significant reduction in GR-
mediated transcriptional activity in leukocytes from socially
isolated indivdiuals (Figure 2).
NF-NB transcriptional response
To determine whether increased transcription of immune
activation genes in high-lonely individuals might stem from
increased activity of the pro-inflammatory NF-NB transcrip-
tion control pathway, TELiS bioinformatics analyses also
assessed the relative distribution of NF-NB/Rel response ele-
ments in differentially expressing promoters. Results showed
a 2.9-fold greater prevalence of NF-NB/Rel motifs among
promoters of genes over-expressed in socially isolated indi-
viduals relative to those over-expressed in socially integrated
individuals (TRANSFAC V$CREL_01 motif: average 0.129 ±
standard error 0.040 sites/promoter for genes over-
expressed in socially integrated individuals versus 0.377 ±
0.086 in isolated; difference p = 0.0108 by t-test) (Figure 2).
Similar results emerged in parametric sensitivity analyses,
with an average 2.69-fold (± 0.47) difference across all 9 par-
ametric combinations of promoter length and motif match
stringency (p = 0.0069), and an average 1.30-fold (± 0.09)
difference in analyses utilizing 5% FDR stringency in gene
selection (p < 0.0001).
GR cross-regulation of NF-NB
Bioinformatic indications of a simulatneous decrease in tran-
scription of GR target genes (.53-fold difference) and an
increase in transcription of NF-NB/Rel target genes (2.69-
fold difference) is consistent with the known cross-inhibition
of those two pathways [37]. Combined TELiS analysis of both
pathways yielded a net 5.08-fold skew in promoter TFBM
distributions (ratio = 2.69/0.53). To ensure that this skewed
motif prevalence reflected the effects of reciprocal signaling
in trans, rather than an inverse relationship between NF-NB
versus GRE TFBMs in the cis-regulatory structure of the
human gene population, we assessed the whole-genome dis-
tribution of NF-NB/GRE prevalence ratios by computing
TFBM prevalence ratios in a similarly sized random sample of
all assayed genes (rather than the specific subset showing dif-
ferential expression in social isolates). Relative to the distri-
bution of cis-structural TFBM prevalence ratios generated by
Transcriptional activity of GR and NF-NB signaling pathwaysFigure 2
T anscriptional activity of GR and NF-NB signaling pathways. TELiS bioinformatics analysis assessed trans-activational activity based on the relative 
prevalence of GR and NF-NB response elements in the promoters of all 209 transcripts over-expressed in high- versus low-lonely individuals (data 
represent mean ± standard error prevalence of response elements within promoters from each group). Contributions of in-trans regulatory influences to 
the observed inverse skew of NF-NB and GR response elements within differentially expressing promoters was tested by comparison to a null distribution 
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   Intriguingly,	  chronic	  stress	  has	  also	  been	  implicated	  to	  play	  a	  role	  in	  the	  regulation	  of	  telomerase	  activity	  (Epel	  et	  al.,	  2004).	  Telomerase	  is	  an	  enzyme	  responsible	  for	  adding	  short	  DNA	  sequence	  repeats	  to	  the	  3’	  end	  of	  DNA	  strands	  found	  at	  the	  ends	  of	  eukaryotic	  chromosomes,	  otherwise	  known	  as	  telomeres	  (Gomez	  et	  al.,	  2012).	  In	  the	  absence	  of	  telomerase	  telomeres	  shorten	  with	  each	  cell	  division,	  therefore	  reduced	  telomerase	  activity	  is	  correlated	  with	  shortened	  telomeres	  after	  cell	  division.	  Studies	  have	  indicated	  that	  telomeric	  length	  is	  more	  indicative	  of	  a	  cell’s	  biological	  “age”	  than	  existence	  measured	  with	  time	  (Campisi,	  1997).	  When	  telomeres	  reach	  a	  certain	  critical	  length,	  p53	  and	  Rb	  pathways	  are	  activated	  forcing	  the	  cell	  into	  senescence	  (Gomez	  et	  al.,	  2012).	  	  Often	  those	  who	  have	  been	  exposed	  to	  extended	  periods	  of	  stress	  are	  said	  to	  have	  “aged	  before	  our	  eyes”.	  Epel	  and	  colleagues	  (2004)	  explored	  this	  theory	  by	  comparing	  the	  length	  of	  peripheral	  blood	  mononuclear	  cell	  telomeres	  in	  women	  with	  elevated	  perceived	  stress	  to	  those	  with	  low	  stress	  levels.	  	  As	  illustrated	  in	  figure	  3,	  they	  found	  that	  women	  who	  were	  chronically	  stressed	  had	  significantly	  reduced	  telomerase	  activity	  and	  telomere	  length	  (Figure	  3;	  Epel	  et	  al.,	  2004).	  In	  addition,	  telomere	  shortening	  has	  been	  associated	  with	  a	  variety	  of	  mood	  disorders	  (Simon	  et	  al.,	  2006).	  These	  studies	  indicate	  that	  chronic	  stress	  contributes	  to	  the	  biological	  “age”	  of	  immune	  cells,	  and	  therefore	  can	  be	  responsible	  for	  premature	  senescence	  of	  these	  cells	  contributing	  to	  reduced	  immune	  function.	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  Figure	  3.	  The	  effect	  of	  chronic	  stress	  on	  telomere	  length	  and	  telomerase	  activity.	  	  (A)	  Women	  exposed	  to	  chronic	  stress	  were	  found	  to	  have	  significantly	  reduced	  telomere	  length	  after	  controlling	  for	  age	  and	  body	  mass	  index.	  	  T/s	  ratio	  is	  the	  standard	  measurement	  of	  average	  telomere	  length	  in	  a	  cell.	  (B)	  	  Women	  exposed	  to	  chronic	  stress	  also	  exhibited	  decreased	  mean	  telomerase	  activity	  as	  measured	  by	  telomerase	  units.	  Adapted	  from	  Epel	  et	  al.,	  2004	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Fig. 2. Telomere length and telomerase activity levels in extreme high- and 
low-stress groups. (A) Average telomere length and SE are shown. The high- 
stress group had shorter telomeres even after controlling for age and BMI [F(1, 
27) = 12.8, P < 0.001]. (B) Average telomerase activity and SE are shown. The 
high-stress group had lower telomerase activity even after controlling for age 
and BMI [F(1, 27) = 3.1, P < 0.05]. Because values for telomerase activity were 
not normally distributed, the values were converted to follow a normal 
distribution by using a natural logarithm transformation. All statistical anal- 
yses were performed on the transformed variable. The raw (unadjusted) levels 
of telomerase are presented throughout because these values are more 
meaningful than transformed values. 
ag  and BMI. Indep ndent of their chronological age and BMI, 
the high-stress group had significantly shorter telomeres (raw 
mean T/S ratio = 1.13 ? 0.17), which converts to 3,110-bp 
telomeres than the low-stress group (raw mean T/S ratio = 
1.33 ? 0.15), which converts to 3,660-bp telomeres (Fig. 2A). 
Because telomere length declines during normal aging, one 
can estimate the years of aging expected to pass to bring the 
relatively long telomeres of the bottom-stress-quartile individu- 
als down to the relatively short lengths of the top-stress-quartile 
individuals. Cross-sectional studies of age versus telomere length 
in the general population show that telomere shortening in 
young adulthood appears minimal in lymphocytes or PBMCs (4, 
17-19) and becomes faster (=60 bp/year) in older age (50-70 
years) (17, 19). There are no studies that estimate average 
expected telomere shortening in the exact age range studied here 
(20-50 years), which largely falls within the young adulthood 
period of minimal loss. Therefore, in translating telomere short- 
en ng to years of aging, we based our e imates on studies 
averaging telomere shortening across adulthood (ages 20-95 
years), which find a loss of 31-63 bp/year (17, 20, 21). Thus, the 
550-bp shortening in the high-stress group indicates that their 
lymphocytes had aged the equivalent of 9-17 additional years, 
compared with the low-stress group. 
Strikingly, the high-stress group also had significantly lower 
telomerase activity (Fig. 2B) and higher oxidative stress than the 
low-stress group. The mean telomerase activity, adjusted for 
BMI and age, was 48% lower in the high-stress group (M = 
0.053 ? 0.016 versus 0.092 ? 0.016 telomerase units per 10,000 
cells; F(1, 27) = 3.1; P < 0.045). The mean oxidative stress index 
was F(3, 22) = 4.5, P < 0.025 (M = 0.052 + 0.010 versus 0.085 ? 
0.010 arbitrary units of isoprostanes/vitamin E). When the 
results were analyzed by high versus low telomere length, the 
conclusions were similar in that the short telomere length group 
had higher perceived stress, higher oxidative stress, and lower 
telomerase activity (see Supporting Text). 
Discussion 
The exact mechanisms that connect the mind to the cell are 
unknown. Although it is well accepted that cell senescence can 
include stress-induced processes, psychological stress has not yet 
been considered as part of the stress pathway. The current 
findings suggest that stress-induced premature senescence in 
p ople might be influenced by chronic or perceived life stress. 
Psychological stress could affect cell aging through at least three 
nonmutually exclusive pathways: immune cell function or distri- 
bution, oxidative stress, or telomerase activity. We considered 
wh ther st ess might have ecreased naive T c lls and increased 
memory T cells [which have shorter telomere length (22)], but 
the data did not support this (Table 2, which is published as 
supporting information on the PNAS web site). Second, stress 
could potentially lead to oxidative stress by means of chronic 
activation of the autonomic and neuroendocrine stress re- 
sponses. Although this hypothesis has never been tested in vivo, 
the relationship between stress hormones and oxidative stress 
has been clearly demonstrated at the cellular level. Glucocorti- 
coids, the primary adrenal hormones secreted during stress, 
increase oxidative stress damage to neurons, in part by increasing 
glutamate and calcium and decreasing antioxidant enzymes (23, 
24). It is also notable that, in women, self-reported distress has 
been related to greater oxidative DNA damage (8-OH-dG) (12). 
Oxidative stress shortens telomeres in cells cultured in vitro (10). 
Our findings that perceived and chronic stress correlated with 
higher oxidative stress and shorter telomere length demonstrate 
this relationship cross-sectionally for the first time in vivo. Lastly, 
if the observed lowered telom ras  activity represents chronic 
levels, it too could have contributed to the shortened telomeres 
in PBMCs. 
Although being a caregiver per se was ot related to telomere 
length, the chronicity of caregiving stress was related to telomere 
length. It is a formal possibility that the association between 
stress and telomere length reported here is in part due to people 
with longer telomeres being psychologically more resistant to 
objective stressors than people with shorter telomeres. Engi- 
neering worms to have longer telomeres resulted in an extension 
of their life spans, even though all of their somatic cells are 
postmitotic and their telomeres do not shorten during aging (25). 
Further, the biochemical pathway involved in this effect of 
telomere length on life span is the same pathway previously 
shown to mediate increased physiological stress resistance in 
response to various genetic variants that increase life span. It is 
unknown whether physiological stress resistance is related to 
psychological stress resistance. Perceived stress may be either 
causally or correlationally related to telomere length. However, 
the relationship between chronicity of caregiving stress (an 
objectively based measure) and telomere length implies that 
stress preceded telomere shortening, because telomere length 
cannot have influenced the number of years one has been a 
caregiver. Clearly, longitudinal studies in which telomere length 
is assayed repeatedly are needed to directly test whether the rate 
of telomere shortening in individuals with higher levels of 
reported stress is actually faster than in individuals with lower 
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Fig. 2. Telomere length and telomerase activity levels in extreme high- and 
low-stress groups. (A) Average telomere length and SE are shown. The high- 
stress group had shorter telomeres even after controlling fo  age nd BMI [F(1, 
27) = 12.8, P < 0.001]. (B) Average telomerase activity a d SE ar  shown. The 
high-stress group had lower telomerase activity even after controlling for age 
and BMI [F(1, 27) = 3.1, P < 0.05]. Because values for telomerase activity were 
ot normally distributed, the values were converted to follow a normal 
distribution by using a natural logarithm transformation. All statistical anal- 
yses were performed on the transformed variable. The raw (unadjusted) levels 
of telomerase are presented throughout because these values are more 
meaningful than transformed values. 
age and BMI. Independent of their chronological age and BMI, 
the high-stress group had significantly shorter telomeres (raw 
mean T/S ratio = 1.13 ? 0.17), which converts to 3,110-bp 
telomeres than the low-stress group (raw mean T/S ratio = 
1.33 ? 0.15), which converts to 3,660-bp telomeres (Fig. 2A). 
Because telomere length declines during normal aging, one 
can estimate the years of aging expected to pass to bring the 
relatively long telomeres of the bottom-stress-quartile individu- 
als down to the rela ively s t lengths of the top-stress-quartile 
individuals. Cross-sectional s udies f age vers s telom re length 
in the general population show that telomere shortening in 
young adulthood appearsminimal in lymphocytes o  PBMCs (4, 
17-19) and b com s faster (=60 bp/year) in older ag  (50-70 
years) (17, 19). There are no studies that es imate average 
expected telomere shortening in the exact age range studied here 
(20-50 years), whic  largely f lls within the young adulthood 
period of minimal loss. Therefore, in translating telomere short- 
ening to years of aging, we based our estimates on studies 
averaging telomere shortening across adulthood (ages 20-95 
years), which find a loss of 31-63 bp/year (17, 20, 21). Thus, the 
550-bp shortening in the high-stress group indicates that their 
lymphocytes had aged the equivalent of 9-17 additional years, 
compared with the low-stress group. 
Strikingly, the high-stress group also had significantly lower 
telomerase activity (Fig. 2B) and higher oxidative stress than the 
low-stress group. The mean telomerase activity, adjusted for 
BMI and age, was 48% lower in the high-stress group (M = 
0.053 ? 0.016 versus 0.092 ? 0.016 telomerase units per 10,000 
cells; F(1, 27) = 3.1; P < 0.045). The mean oxidative stress index 
was F(3, 22) = 4.5, P < 0.025 (M = 0.052 + 0.010 versus 0.085 ? 
0.010 arbitrary units of isoprostanes/vitamin E). When the 
results were analyzed by high versus low telomere length, the 
conclusions were similar in that the short telomere length group 
had higher perceived stress, higher oxidative stress, and lower 
telomerase activity (see Supporting Text). 
Discussion 
The exact mechanisms that connect the mind to the cell are 
unknown. Although it is well accepted that cell senescence can 
include stress-induced processes, psychological stress has not yet 
been considered as part of the stress pathway. The current 
findings suggest that stress-induced premature senescence in 
people might be influenced by chronic or perceived life stress. 
Psychological stress could affect cell aging through at least three 
nonmutually exclusive pathways: immune cell function or distri- 
bution, oxidative stress, or telomerase activity. We considered 
whether stress might have decreased naive T cells and increased 
memory T cells [which have shorter telomere length (22)], but 
the data did not support this (Table 2, which is published as 
supporting information on the PNAS web site). Second, stress 
could potentially lead to oxidative stress by means of chronic 
activation of the autonomic and neuroendocrine stress re- 
sponses. Although this hypothesis has never been tested in vivo, 
the relationship between stress hormones and oxidative stress 
has been clearly demonstrated at the cellular level. Glucocorti- 
coids, the primary adrenal hormones secreted during stress, 
increase oxidative stress damage to neurons, in part by increasing 
glutamate and calcium and decreasing antioxidant enzymes (23, 
24). It is also notable that, in women, self-reported distress has 
been related to greater oxidative DNA damage (8-OH-dG) (12). 
Oxidative stress shortens telomeres in cells cultured in vitro (10). 
Our findings that perceived and chronic stress correlated with 
higher oxidative stress and shorter telomere length demonstrate 
this relationship cross-sectionally for the first time in vivo. Lastly, 
if the observed lowered telomerase activity represents chronic 
levels, it too could have contributed to the shortened telomeres 
in PBMCs. 
Although being a caregiver per se was not related to telomere 
length, the chronicity of caregiving stress was related to telomere 
length. It is a formal possibility that the association between 
stress and telomere length reported here is in part due to people 
with longer telomeres being psychologically more resistant to 
objective stressors than people with shorter telomeres. Engi- 
neering worms to have longer telomeres resulted in an extension 
of their life spans, even though all of their somatic cells are 
postmitotic and their telomeres do not shorten during aging (25). 
Further, the biochemical pathway involved in this effect of 
telomere length on life span is the same pathway previously 
shown to mediate increased physiological stress resistance in 
response to various genetic variants that increase life span. It is 
unknown whether physiological stress resistance is related to 
psychological stress resistance. Perceived stress may be either 
causally or correlationally related to telomere length. However, 
the relationship between chronicity of caregiving stress (an 
objectively based measure) and telomere length implies that 
stress preceded telomere shortening, because telomere length 
cannot have influenced the number of years one has been a 
caregiver. Clearly, longitudinal studies in which telomere length 
is assayed repeatedly are needed to directly test whether the rate 
of telomere shortening in individuals with higher levels of 
reported stress is actually faster than in individuals with lower 
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glucocorticoids	  which	  can	  eventually	  result	  in	  glucocorticoid	  resistance	  (Stark	  et	  al.,	  2001).	  	  While	  this	  phenomenon	  has	  been	  noted	  in	  a	  number	  of	  different	  patient	  populations,	  the	  molecular	  mechanisms	  governing	  glucocorticoid	  resistance	  have	  yet	  to	  be	  fully	  elucidated	  (Cohen	  et	  al.,	  2012).	  Potential	  mechanisms	  are	  depicted	  in	  figure	  4	  (Figure	  4;	  Schmidt	  et	  al.,	  2004).	  There	  is	  evidence	  that	  continuous	  exposure	  to	  elevated	  levels	  of	  glucocorticoids	  cause	  genomic	  alterations	  that	  result	  in	  down-­‐regulation	  of	  glucocorticoid	  receptor	  (GR)	  by	  various	  mechanisms	  (	  Schmidt	  et	  al.,	  2004).	  In	  addition,	  a	  number	  of	  papers	  have	  identified	  impaired	  nuclear	  translocation	  of	  the	  GR	  receptor	  as	  an	  important	  step	  in	  decreased	  glucocorticoid	  sensitivity	  (De	  Iudicibus	  et	  al.,	  2011;	  Jung	  et	  al.,	  2015).	  In	  his	  2009	  review	  Barnes	  listed	  potential	  mechanisms	  for	  glucocorticoid	  resistance	  including	  GR	  receptor	  modifications,	  up-­‐regulation	  of	  GR	  splicing	  variants,	  up-­‐regulation	  of	  pro-­‐inflammatory	  transcription	  factors,	  increased	  transport	  of	  glucocorticoids	  out	  of	  the	  cytoplasm,	  and	  defective	  epigenetic	  regulation	  of	  anti-­‐inflammatory	  genes	  (Barnes	  &	  Adcock,	  2009).	  	  	  	  	  
	  20	  
	  Figure	  4.	  Proposed	  mechanisms	  mediating	  glucocorticoid	  resistance.	  1)	  Insufficient	  ligand	  concentration.	  2)	  GR	  transcriptional	  and	  translational	  errors.	  3)	  Mutations	  in	  proteins	  that	  associate	  with	  GR.	  4)	  Mutations	  in	  downstream	  signaling	  pathway	  5)	  Interference	  from	  other	  signaling	  pathways.	  Adapted	  from	  Schmidt	  et	  al.,	  2004.	  	  	   A	  2015	  study	  from	  Jung	  et	  al.	  explored	  the	  consequences	  of	  repeated	  social	  defeat	  stress	  (RSD)	  on	  epigenetic	  signatures	  and	  miRNA	  expression	  of	  splenic	  macrophages.	  miRNAs	  are	  non-­‐coding	  RNA	  that	  are	  complementary	  to	  a	  target	  mRNA.	  	  When	  expressed,	  they	  hybridize	  with	  their	  complementary	  mRNA	  and	  prevent	  it	  from	  associating	  with	  ribosomes	  essentially	  halting	  translation	  of	  the	  gene’s	  protein	  product	  (Jung	  et	  al.,	  2015).	  	  RSD	  up-­‐regulated	  nine	  miRNAs	  that	  were	  predicted	  to	  complement	  GR’s	  mRNA	  transcript.	  	  In	  addition,	  RSD	  causes	  the	  activation	  of	  pro-­‐inflammatory	  genes	  through	  promoter	  demethylation	  and	  histone	  
caused by regulatorymechanisms, therapeutic reversal of GC
resistance might become an option.
An almost endless number of possible molecular mechan-
isms for GC resistance can be envisaged along the signal
transduction pathways triggered by GC (Figure 4), and some
of these mechanisms have recently been reviewed else-
where.5,8,9,52,86) Conceptually, they may be grouped into
‘upstream’ and ‘downstream’ mechanisms. The former con-
cern the GR, its ligand and GR-associated proteins that
control its function, and have the potential to affect most, if not
all, GC effects while the latter interfere with, and affect, only
individual GC responses. In lymphoid malignancies, clinically
relevant GC resistancemeans continuous expansion of tumor
cells in the presence of GC, requiring resistance to both
apoptosis induction and GC-mediated cell cycle arrest,
processes that, at least in ALL cell lines, follow distinct
pathways.6 However, to simultaneously interfere with multiple
pathways via ‘downstreammechanisms’ is considerably more
complex than through ‘upstream mechanisms’. Indeed,
convincing evidence for a causative role in resistance to
GC-induced apoptosis has so far mainly been provided for
‘upstream mechanisms’.
‘Upstream mechanisms-1’: insufficient ligand
Most apical in the response is the requirement for sufficient
intracellular levels of biologically active GC. This parameter is
technically difficult to assess, but GC-like bioactivity can be
determined in the plasma of patients during therapy.87
Insufficient plasma levels may result from impaired uptake,
increased steroid-binding proteins in the circulation or
reduced converting enzyme activity, if prodrugs like predni-
sone are used. Intracellular GC levels may be reduced by
overexpression of members of the large ABC transporter
family, most notably themdr-1 gene- encoded P-glycoprotein
and themultidrug resistance-associated protein, MRP, as well
as the lung-resistance protein (LRP), amajor vault protein that
formally does not belong to the ABC family but is still
implicated in drug resistance (reviewed in Gottesman
et al.88). In addition to affecting apoptotic responses to other
agents as well, this form of GC resistance is characterized by
its sensitivity to Pgp inhibitors, like verapramil or cyclosporin
A, and its differing efficiency towards variousGC analogues,89
which might open therapeutic possibilities. Mdr-1 gene over-
expression has been made responsible for GC resistance in a
mouse thymoma line,90 but what role this form of GC
resistance might play in patients is not clear.8,88,91 Finally,
GC resistance might be caused by expression of GC-
metabolizing enzymes such as 11b-hydroxysteroid dehydro-
genase type 2 that converts cortisol into inactive cortisone, as
has been shown in rat osteosarcoma cells,92 or mouse
osteoblasts/osteocytes14 transgenic for this enzyme.
‘Upstream mechanisms-2’: GR mutations, splice
variants or insufficient expression
The next checkpoint in the pathway is the GR itself where
mutations, occurrence of GR variants and insufficient expre-
ssion might cause resistance. Numerous loss-of-function
mutations in the GR gene have been observed in GC-
resistant humanALL cell lines (e.g., Hala et al.42 andStrasser-
Wozak et al.93), but whether GR mutations constitute a major
resistance mechanism in vivo remains unresolved. The
combination of GC and chemotherapy, with its mutagenic
potential, might indeed favor the development of, and
subsequent selection for, GR mutations. However, one study
found no evidence of mutations in the DNA- and ligand-
binding domains of the GR in 22 chronic lymphatic leukemia
patients subjected to combination chemotherapy,94 and
another study withB50 children with relapsed ALL provided
only limited evidence for GR mutations as the cause of GC
resistance (J Irving et al., submitted for publication).
GC resistance may also be caused by increased expres-
sion of GR variants (Figure 1) resulting from alternative
splicing, polyadenylation or translational initiation, namely
GR-b, GRg, GR-P/GR-d, GR-A and GR-B (for citations to the
original literature see Tissing et al.8 and Kofler et al.52). GR-P/
GR-d andGR-Awere detected in a GC-resistant myeloma cell
line, and GR-P in a number of hematopoietic and other
malignancies as well as in normal lymphocytes, but how these
variantsmight affect GC sensitivity remains controversial.95,96
The GR-b splice variant reportedly encoded a dominant
negative GR protein97,98 and has been implicated in various
forms of GC resistance, including patients with lymphoblastic
malignancies.99,100 However, there is little, if any, GRb
expression in various hematopoietic tumors, which makes
its role in resistance development questionable.50,96,101
Indeed, Haarman et al.102 concluded that GRb is not involved
in GC resistance in childhood leukemia, although a possible
involvement of GRg in certain childhood leukemia subgroups
could not be excluded. Whether GR-B affects sensitivity to
GC-induced apoptosis in lymphoid malignancies is unknown.
GRa is the major functional GR isoform and, as discussed
above, its expression is a critical factor for GC sensitivity in
i ure 4 Principal mechanisms of GC resistance. Possible r sista ce
mechanisms were organized along the GC signaling pathway and numbered
consecutively: ‘Upstream’ m chanisms 1 and 2 have been detailed in the text,
upstream mechanism 3 concerns deficiencies in GR-associated proteins in the
cytoplasm (3A) and nucleus (3B), respectively (discussed in Kofler et al.52).
‘Downstream’ mechanisms encompass (4) defects in components of the specific
response pathway or (5) crosstalk from other signaling pathways that interfere
with and antagonize the death response. Abbreviations: 11b-HSD, 11b-
hydroxysteroid dehydrogenase type 2; C, chaperones; CF, transcription
cofactors, GC, glucocorticoid; GR, glucocorticoid receptor; Pgp, P-glycoprotein;
R, ribosome
Glucocorticoid-induced apoptosis and resistance
S Schmidt et al
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acetylation,	  both	  activating	  epigenetic	  marks.	  	  As	  shown	  in	  figure	  5,	  they	  propose	  a	  theoretical	  molecular	  cascade	  though	  which	  chronic	  psychosocial	  stress	  induces	  glucocorticoid	  resistance	  via	  epigenetic	  regulation	  (Figure	  5;	  Jung	  et	  al.,	  2015).	  	  	  	  	  	  	  	  	  
	  Figure	  5.	  A	  proposed	  mechanism	  for	  chronic	  psychosocial	  stress	  induced	  glucocorticoid	  resistance.	  Jung	  et	  al.	  hypothesized	  that	  chronic	  psychosocial	  stress	  exposure	  leads	  to	  epigenetic	  modifications	  that	  result	  in	  activation	  of	  inflammatory	  cytokine	  signaling,	  and	  down-­‐regulation	  of	  GR	  and	  FKBP52	  translation.	  	  FKBP52	  is	  the	  protein	  responsible	  for	  GR	  nuclear	  translocation,	  and	  is	  therefore	  required	  for	  the	  activation	  of	  GR	  induced	  anti-­‐inflammatory	  gene-­‐expression	  programs.	  Adapted	  from	  Jung	  et	  al.,	  2015.	  	  	  
sites wrapped around acetylated histones were available for tran-
scription. Although the decreased HDAC2 mRNA expression in
splenic macrophages by RSD was not expected, this result is con-
sistent with Elliott et al., (2010) showing that a 10-day social
defeat paradigm induced a significant decrease in HDAC2 expres-
sion in the paraventricular nucleus. The decrease in HDAC2 expres-
sion indicates in general that RSD causes splenic macrophages to
have less capacity to repress histone activation and transcriptional
activation, and, therefore, yield increased gene expression because
histone acetyltransferase is inversely associated with HDAC (Guo
et al., 2011). Moreover, the literature on GC sensitivity and HDAC2
showed the positive correlation between HDAC2 quantity and GC
sensitivity in macrophages (Kadmiel and Cidlowski, 2013; Kassel
and Herrlich, 2007). In this case, RSD-induced decrease in HDAC2
mRNA expression may be explainable for RSD-induced GC resis-
tance. However, since we did not report its protein expression
and expression of other subtypes; future studies are needed. Based
on our results showing both the reduced amount of methylated
DNA and decreased mRNA expression of DNMT3a, DNMT3b and
HDAC2, it is likely that RSD induced chromatin activation, higher
levels of transcriptional activation due to at least in part decreased
DNA methylation status and, therefore, more gene expression. This
suggestion is supported, especially, by recent findings (Chen et al.,
2012; Ito et al., 2000; Malhotra et al., 2011) that HDAC2 plays a
critical role in the suppressive action of GC–GC receptor complexes
by increasing deacetylation on certain sites of previously activated
genes, especially inflammatory genes.
We investigated the effects of RSD onmiRNA expression in sple-
nic macrophages. miRNAs are small non-coding RNAs that are
known to play an important role in regulating target mRNAs by
mRNA repression and degradation. We report that RSD induced
significantly increased expression of 9 miRNAs that were predicted
to interact with mRNAs of the GC receptor (6 miRNAs), mineralo-
corticoid receptor (3 miRNAs) and FKBP52 (2 miRNAs). By qPCR,
we verified 2 different miRNAs (miR-29b and miR-340) that were
predicted to interact with mRNA expression of GC receptor. The
results showed a similar pattern of enhanced expression as shown
in the miRNA profiling data. Their target mRNA expression of GC
receptor was negatively correlated with the expression of each
miRNA (miR-29b or miR-340). To verify a direct, biological effect
of each miRNA on their target gene expression, we conducted an
in vitro study, in which miR-29b or 340 was overexpressed in
L929 cells to determine whether the mRNA expression of their tar-
get gene (GC receptor) was influenced by the miRNA. LPS-induced
expression of GC receptor was significantly blocked by the overex-
pression of miR-29b and 340. This result confirmed direct effects of
these miRNA on GC receptor gene expression. This result indicated
that RSD-induced GC resistance in splenic macrophages was, at
least partially, stimulated by the miRNAs. Although a recent study
(Ma et al., 2011) showed that miR-29b suppresses innate and
adaptive immune responses and suggested that miR-29b plays an
important role in immune regulation, very few studies have been
published to investigate roles of these GC receptor-targeted miR-
NAs in immune cells, including macrophages. Therefore, it is neces-
sary to elucidate, in future investigations, roles of these miRNA in
immunity in addition to investigating whether the direct influence
of these miRNAs on their target mRNAs is due to their direct bind-
ing capability to 30UTR of GC receptor mRNA.
In this study, we examined the underlying molecular mecha-
nisms of RSD-induced GC resistance in splenic macrophages. This
study provided evidence of a molecular mechanistic explanation
for GC resistance in splenic macrophages. The data showed that
RSD induced a significant decrease in mRNA expression of the GC
receptor, mineralocorticoid receptor, FKBP52, DNMT3a, DNMT3b
Fig. 4. Diagram of the hypothesized underlying mechanisms for the RSD-induced glucocorticoid resistance in splenic macrophag s (CD11b+ cells). For the glucocorticoid
resistance induced by chronic social stress, chromatin modification includes DNA and histone methylation/demethylation and histone acetylation/deacetylation based on the
present study.
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Glucocorticoid	  resistance	  has	  consequences	  outside	  of	  the	  immune	  system.	  	  Down-­‐regulation	  of	  GR	  in	  the	  pituitary	  and	  hypothalamus	  interferes	  with	  cortisol’s	  native	  negative-­‐feed	  back	  loops	  causing	  a	  further	  over	  production	  of	  glucocorticoids,	  mineralocorticoids,	  and	  androgens	  (Figure	  6;	  van	  Rossum	  &	  Lamberts,	  2006).	  	  	  
	  	  	  Figure	  6.	  Glucocorticoid	  resistance	  induced	  interference	  of	  HPA	  axis	  regulation.	  (A)	  Normally,	  GR	  receptors	  located	  in	  the	  pituitary	  and	  hypothalamus	  participate	  in	  a	  negative-­‐feedback	  loop	  that	  inhibits	  over-­‐production	  of	  glucocorticoids.	  (B)	  Glucocorticoid	  resistance	  prevents	  GRs	  on	  the	  pituitary	  and	  hypothalamus	  from	  detecting	  glucocorticoid	  concentrations	  in	  systemic	  circulation.	  	  This	  prevents	  the	  negative	  feedback	  mechanisms	  and	  results	  in	  an	  over-­‐production	  of	  androgens,	  mineralocorticoids,	  and	  glucocorticoids,	  which	  further	  contribute	  to	  the	  established	  glucocorticoid	  resistance.	  Adapted	  from	  van	  Rossum	  &	  Lamberts,	  2006.	  	  	  	  
hypothalamus, which receives stimuli from the central nervous system.3 In response to
these stimuli (e.g. physical or psychological stress), neurons in the paraventricular nu-
cleus of the hypothalamus secrete corticotropin-releasing hormone (CRH) and its co-
secretagogue vasopressin.4 As a result, the pituitary is stimulated to secrete ACTH5
which is synthesized as part of a large precursor, pro-opiomelanocortin (POMC).6
ACTH stimulates the adrenal glands to produce GCs (Figure 1A). Due to GR defects,
cortisol has impaired actions through the GR. As a consequence, the central negative
feedback of GCs is diminished, GC production by the adrenal is elevated, and cortisol
binds with high affinity to the mineralocorticoid receptor (Figure 1B). Symptoms in pa-
tients with cortisol resistance are the consequence of this compensatory hyperactivity of
the hypothalamicepituitaryeadrenal (HPA) axis (see Table 1). Due to these elevated
ACTH, levels patients suffer from an overproduction of mineralocorticoids, leading to
hypertension, hypokalaemic alkalosis, and fatigue. Females also show signs of hyperan-
drogenism e such as hirsut sm, male pattern of baldness a d menstrual irregularities e
due to higher adrenal production of androgens. A female patient suffering from
generalized GC resistance is depicted in Figure 2. In males the gonadal production of an-
drogens is much higher, which outweighs the increased adrenal androgen production. In
physiological conditions, tissues which have an important mineralocorticoid function















Figure 1. Simplified overview of the regulation of the hypothalamicepituitaryeadrenal (HPA) axis in the
normal situation (A) and in the syndrome of GC resistance (B). In normal conditions corticotropin-releasing
hormone (CRH) is secreted by the hypothalamus, which stimulates the pituitary to produce adrenocortico-
tropin (ACTH), which i its turn stimulates the adrenal glands to s crete gluc corticoids (GCs, the main GC
in humans bei g corti ol), mineralocorticoids and androgens. Cortisol inhibits its own production, at the
level of both the pituitary and the hypothalamus. In the case of GC resistance, the negative feedback mech-
anism, which is mediated by the GR, is impaired. As a result, the HPA axis becomes hyperactivated and the
production of the mentioned adrenal hormones increases, resulting in symptoms of overproduction of
mineralocorticoids and androgens (the latter in particular in women), but no signs of GC excess due to
the defective GR.
612 E. F. C. van Rossum and S. W. J. Lamberts
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A	  2012	  study	  from	  Cohen	  et	  al.	  explored	  how	  psychosocial	  stress-­‐induced	  glucocorticoid	  resistance	  affected	  the	  inflammatory	  response	  after	  controlled	  exposure	  to	  a	  virus.	  They	  found	  that	  long-­‐term	  stress	  correlated	  to	  glucocorticoid	  resistance,	  and	  that	  those	  with	  long-­‐term	  stress	  were	  at	  higher	  risk	  of	  developing	  a	  cold	  after	  infection.	  In	  a	  second	  experiment,	  they	  confirmed	  the	  pro-­‐inflammatory	  effect	  of	  glucocorticoid	  resistance	  by	  correlating	  long-­‐term	  stress	  to	  increased	  production	  of	  pro-­‐inflammatory	  cytokines	  after	  viral	  exposure.	  	  This	  indicates	  that	  chronic	  psychosocial	  stress	  exposure	  causes	  the	  development	  of	  glucocorticoid	  resistance	  in	  multiple	  cell	  types	  that	  result	  in	  potentially	  oncogenic	  pro-­‐inflammatory	  changes.	  In	  fact,	  glucocorticoid	  resistance	  has	  been	  identified	  as	  a	  risk	  factor	  in	  lymphoid	  malignancies	  (Schmidt	  et	  al.,	  2004).	  	   Chronic	  psychosocial	  stress	  manifests	  its	  harmful	  physiologic	  properties	  in	  part	  via	  glucocorticoid	  resistance.	  	  Chronic	  exposure	  to	  psychosocial	  stress	  induces	  genomic	  and	  epigenomic	  alterations	  that	  result	  in	  glucocorticoid	  resistance	  and	  activation	  pro-­‐inflammatory	  gene	  expression	  programs.	  Alleviation	  of	  glucocorticoid	  resistance	  may	  be	  one	  of	  the	  key	  mechanisms	  through	  which	  mindfulness	  elicits	  its	  stress-­‐buffering	  properties.	  	  Currently,	  there	  is	  little	  research	  exploring	  the	  relationship	  between	  mindfulness	  and	  GR	  functionality.	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Chronic	  stress	  induces	  chronic	  low-­‐level	  inflammation	  	   Acute	  inflammation	  is	  a	  natural	  immune	  response	  that	  evolved	  to	  help	  fight	  pathogenic	  infections	  (Van	  Bogaert	  et	  al.,	  2010).	  Inflammatory	  processes	  are	  typically	  activated	  by	  exposure	  to	  infection	  or	  tissue	  injury.	  These	  triggers	  stimulate	  production	  of	  cytokines,	  chemokines,	  vasoactive	  amines,	  eicosanoids	  and	  other	  immunoactive	  molecules.	  Plasma	  proteins	  recruit	  leucocytes	  to	  the	  tissue	  site	  in	  question,	  facilitating	  the	  degradation	  of	  pathogens	  from	  the	  body	  (Medzhitov,	  2008).	  	  While	  acute	  inflammation	  is	  necessary	  for	  survival,	  recent	  research	  has	  implicated	  chronic	  inflammation	  as	  a	  risk	  factor	  that	  contributes	  to	  cardiovascular	  disease,	  type-­‐2	  diabetes,	  inflammatory	  bowel	  disease,	  stroke,	  Alzheimer’s	  disease,	  arthritis,	  obesity,	  osteoporosis,	  depression,	  and	  cancer	  (Hotamisligil,	  2006;	  Landskron	  et	  al.,	  2014;	  Leonard,	  2007;	  Pradhan	  et	  al.,	  2015;	  see	  Murakami	  and	  Hirano,	  2013	  for	  review).	  	  Due	  to	  the	  powerful,	  cytotoxic	  nature	  of	  inflammation,	  tight	  anti-­‐inflammatory	  regulation	  is	  necessary	  to	  prevent	  immune	  responses	  from	  becoming	  immunopathological	  (Dhabhar,	  2014).	  Activation	  of	  the	  HPA	  axis	  and	  the	  subsequent	  genomic	  alternations	  initiated	  by	  glucocorticoids	  are	  necessary	  to	  terminate	  immune-­‐mediated	  inflammatory	  responses	  (Stark	  et	  al.,	  2001).	  During	  exposure	  to	  chronic	  stress,	  glucocorticoid	  resistance	  within	  immune	  cells	  inhibits	  the	  body’s	  innate	  mechanisms	  to	  regulate	  inflammation	  (Cohen	  et	  al.,	  2012).	  	  In	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addition,	  chronic	  stress	  causes	  continuous	  stimulation	  of	  the	  SAM	  axis	  to	  produce	  catecholamines.	  Norepinephrine	  stimulates	  the	  production	  of	  pro-­‐inflammatory	  cytokines	  such	  as	  Il-­‐1,	  Il-­‐6,	  C-­‐reactive	  protein	  via	  NF-­‐kB	  dependent	  gene	  expression	  in	  immune	  cells	  (Bierhaus	  et	  al.,	  2002;	  Jung	  et	  al.,	  2015;	  Kiecolt-­‐glaser	  et	  al.,	  2003).	  NF-­‐kB	  mediated	  alterations	  of	  immune	  cell	  gene	  expression	  programs	  results	  in	  immune	  activation	  and	  pro-­‐inflammatory	  cytokine	  signaling	  (Bierhaus	  et	  al.,	  2002).	  Elevated	  levels	  of	  NF-­‐kB	  have	  been	  tied	  to	  psychosocial	  stress	  exposure	  (Kuebler	  et	  al.,	  2014;	  Nagabhushan	  et	  al.,	  2001).	  Expression	  of	  NF-­‐kB	  is	  associated	  with	  increased	  oxidative	  stress	  (Bhasin	  et	  al.,	  2013).	  Constant	  activation	  of	  this	  system,	  in	  combination	  with	  developed	  glucocorticoid	  resistance	  results	  in	  the	  presence	  of	  persistent,	  systematic	  low-­‐levels	  of	  inflammation	  within	  chronically	  stressed	  individuals	  (Rohleder,	  2014).	  	  Figure	  7	  illustrates	  how	  persistent	  inflammation	  contributes	  to	  oncogenesis	  	  (Figure	  7;	  Qiagen	  Inc.,	  2011)	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  Figure	  7.	  	  The	  mechanisms	  by	  which	  inflammation	  contributes	  to	  oncogenesis.	  Chronic	  inflammation	  decreases	  DNA	  damage	  repair	  mechanisms,	  increasing	  transcription	  of	  oncogenes,	  and	  mutates	  DNA	  which	  leads	  to	  immune	  system	  evasion	  and	  metastasis.	  Adapted	  from	  Qiagen,	  Inc.	  	  In	  addition	  to	  inhibiting	  the	  body’s	  ability	  to	  efficiently	  terminate	  inflammatory	  responses	  through	  glucocorticoid	  resistance,	  chronic	  stress	  results	  in	  elevated	  concentrations	  of	  reactive	  oxygen	  species	  that	  further	  contributes	  to	  the	  progression	  of	  chronic	  inflammation	  and	  cancer.	  The	  immune	  cells	  of	  those	  exposed	  to	  chronic	  stress	  have	  elevated	  markers	  of	  oxidative	  damage	  to	  RNA,	  DNA	  and	  lipid	  peroxidation	  (Aschbacher	  et	  al.,	  2013).	  	  Although	  the	  mechanism	  is	  currently	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unknown,	  elevated	  urine	  concentrations	  of	  glucocorticoids	  is	  associated	  with	  increased	  oxidative	  damage	  to	  DNA	  (Joergensen	  et	  al.,	  2011).	  	  This	  increased	  oxidative	  damage	  has	  a	  host	  of	  health	  consequences	  including	  increasing	  the	  likelihood	  of	  developing	  cancer	  (Figure	  8;	  Federico	  et	  al.,	  2007).	  Chronic	  inflammation	  has	  been	  found	  to	  decrease	  genomic	  stability,	  increase	  angiogenesis,	  and	  induce	  epigenetic	  alterations	  that	  result	  in	  cell	  proliferation.	  	  In	  addition,	  chronic	  inflammation	  has	  been	  found	  to	  play	  a	  role	  in	  regulating	  the	  expression	  of	  many	  important	  oncogenes	  and	  tumor	  suppressor	  genes	  (Schetter	  et	  al.,	  2010).	  Importantly,	  increased	  concentrations	  of	  reactive	  oxygen	  species	  due	  to	  chronic	  inflammation	  have	  been	  found	  to	  inhibit	  apoptosis,	  and	  reduce	  the	  effectiveness	  of	  antineoplastic	  agents	  as	  cancer	  treatments	  (Conklin,	  2004).	  	  
	  Figure	  8.	  	  The	  carcinogenic	  mechanisms	  by	  which	  free	  radicals	  initiate	  oncogenesis	  (Federico	  et	  al.,	  2007).	  
tic drugs exert their action of cell death promotion by increasing
ROI production.38,39
The start of carcinogenesis mediated by ROI and RNI following
chronic inflammation may be direct (oxidation, nitration, halogen-
ation of nuclear DNA, RNA and lipids), or may be mediated by
the products of ROI-RNI and proteins, lipids and carbohydrates
that are capable of forming DNA adducts. ROI can also increase
the expression of transcriptional factors including c-fos and c-jun
oncogenes involved in neoplastic transformation.
Direct effect of free radicals on DNA damage
and carcinogenesis
To date, more than 100 oxidized DNA products have been
identified. ROI-induced DNA damage involves single- or double-
stranded DNA breaks; purine, pyrimidine or deoxyribose modifi-
cations; DNA intrastrand adducts; and DNA protein crosslinks.40
DNA damage can result in either arrest or induction of transcrip-
tion, induction of signal transduction pathways, replication errors
and genomic instability, all processes associated with carcinogen-
esis.41,42 NO reacts with superoxide (O2
2) to form peroxynitrite
(ONOO2), a highly reactive species that induce nitrative and oxi-
dative DNA damage. In fact, ONOO2 mediates the formation of
8-oxo-7,8-dihydro-20-deoxyguanosine43 and 8-nitroguanine,44,45
which has also been suggested as a potential biomarker of inflam-
mation-related carcinogenesis.42,46 Recent evidences indicate that
8-nitroguanosine is a highly redox-active molecule47,48 and that
8-nitroguanine is a mutagenic substance, which preferentially
leads to G>T transversions.44,49 Indeed, G>T transversions have
been observed in vivo in the ras gene50 and the p53 tumor suppres-
sor gene, in lung and liver cancer.51,52 These findings indicate that
the DNA damage mediated by ROI and RNI may participate to
carcinogenesis, both via activation of proto-oncogenes and inacti-
vation of tumor suppressor genes. In the carcinogenesis also, the
oxidative damage of mitochondria is strongly involved.42 In fact,
hydrogen peroxide and other reactive oxygen species activate nu-
clear genes that regulate the biogenesis, transcription and replica-
tion of the mitochondrial genome. Although the rate of tumor cells
that possess mutated mitochondrial DNA and the cancer processes
to which mitochondrial DNA alterations participate have not been
satisfactorily established, a significant amount of information sup-
port the involvement of the mitochondria in carcinogenesis.42
Fragments of mitochondrial DNA have been found to be inserted
into nuclear DNA, suggesting a possible mechanism of oncogene
activation. Mitochondrial DNA (mtDNA), which is bound to the
inner mitochondria membrane, is particularly liable to oxidative
damage because of the lack of histone proteins, the presence of
incomplete repairing mechanisms53–55 and its proximity to the
mitochondrial electron transport chain. Damage to mtDNA causes
mitochondrial respiratory chain dysfunction, which in turn
increases the production of hydroxyl radicals which are the major
source of oxidative damage for DNA.56–58 MtDNA also encodes
essential proteins involved in the phosphorylation processes,59 and
its damage is associated with a cascade of reactions that amplify
the oxidative stress.60–63 Mutations and altered expression in
mitochondrial genes encoding for complexes I, III, IV and V, and
in the hypervariable regions of mitochondrial DNA, have been
identified in various human cancers.64,65
The role of ROI- and RNI-derived products
on carcinogenesis
Free radicals immediately react with all components of cells by
forming stable products. Proteins are more susceptible to oxida-
tion by free radicals. In the global cellular economy, the oxidation
of SH groups of cysteine reduces the activity of various enzymes
as well as the synthesis of GSH, which is the main intracellular
free radical scavenger.
The oxidation of lipids induces the formation of aldehydes and
lipid peroxides. These molecules, at very low and nontoxic con-
centrations, act as signaling transductors of ROI-mediated meta-
bolic reactions, and therefore, they modulate several cell functions
including gene expression and cell proliferation.66 In high concen-
trations, lipid-derived products are considered the more damaging
species because they easily react with proteins, DNA and phos-
pholipids, generating a variety of intra- and intermolecular toxic
covalent adducts that lead to the propagation and amplification of
oxidative stress.67 This has been demonstrated in human cancero-
genesis.68–70 Lipid hydroperoxides are formed in vivo through the
action of ROI on polyunsaturated fatty acids, both directly and as
specific products of lipoxygenase (LOX) and COX activities.67
Cell membranes are the main target for lipid peroxidation. Lipid
peroxides cause cell damage by its decomposition in breakdown
toxic products that are bifunctional aldehydes,71 which are rela-
tively stable and able to diffuse in and outside the cell. The most
abundant ROI–lipid-derived product is—in conditions of oxida-
tive stress—the 4-hydroxynonenal (HNE). At low levels it pro-
motes cell proliferation, while at a higher concentration it induces
oxidative alterations of DNA72 and apoptosis.73–75 Therefore, 4-
HNE is directly involved in cell cycle control,76 and in human
cancer, it causes mutation in the p53 gene expression.68 4-HNE
forms etheno adducts with DNA and upregulates COX-2 expres-
sion.77 It has previously been stressed that COX2 expression indu-
ces an enhanced production of ROI. The breakdown of membrane
lipid hydroperoxides also increases the levels of MDA,78 which
can react with DNA bases G, A, and C by forming adducts M1G,
M1A and M1C, respectively.79 M1G adducts have been found in
human tissues at levels as high as 1.2 adducts per 106 bases
FIGURE 3 – The main steps that link inflammation to cancer via free
radical-mediated processes. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
FIGURE 4 – The role of free radicals on carcinogenesis. [Color
figure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
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In	  their	  2012	  review,	  Zhu	  et	  al.	  suggested	  regulating	  the	  inflammatory	  microenvironment	  around	  tumor	  sites	  to	  help	  increase	  the	  efficacy	  of	  current	  chemotherapeutics.	  	  Non-­‐steroidal	  anti-­‐inflammatory	  drugs	  (NSAID)	  have	  been	  used	  with	  repeated	  success	  to	  enhance	  radiation	  and	  chemotherapeutic	  treatment.	  They	  act	  by	  inhibiting	  COX-­‐2	  gene	  transcription	  and	  inhibiting	  prostaglandin	  production.	  In	  addition	  to	  a	  number	  of	  other	  anti-­‐tumor	  effects	  NSAIDs	  inhibits	  the	  prostaglandin-­‐regulated	  production	  of	  VEGF	  and	  the	  process	  of	  angiogenesis	  (Amano	  et	  al.,	  2003;	  de	  Groot	  et	  al.,	  2007).	  This	  information	  suggests	  that	  a	  therapy	  targeted	  towards	  reducing	  chronic	  inflammation	  may	  have	  anti-­‐cancer	  effects.	  
	  
Effect	  of	  Mindfulness	  on	  Psychosocial	  Stress	  	   In	  1989,	  Cohen	  and	  Edwards	  attempted	  to	  explain	  mindfulness’s	  clinical	  benefits	  through	  the	  stress-­‐buffering	  hypothesis.	  An	  important	  implication	  of	  this	  theory	  is	  the	  necessity	  of	  exposure	  to	  psychosocial	  stress	  for	  the	  clinical	  benefits	  of	  mindfulness	  to	  be	  observable	  (Brown,	  2012).	  In	  order	  to	  objectively	  analyze	  mindfulness’s	  impact	  on	  stress	  perception,	  Brown	  and	  Ryan	  developed	  the	  mindful	  attention	  awareness	  scale	  (MAAS)	  to	  measure	  a	  subject’s	  dispositional	  mindfulness.	  The	  MAAS	  is	  designed	  to	  indicate	  awareness	  of	  internal	  physical	  and	  psychological	  experience.	  They	  surveyed	  cancer	  survivors	  to	  find	  that	  increased	  mindfulness	  score	  on	  the	  MAAS	  was	  correlated	  with	  lower	  levels	  of	  mood	  disturbances	  and	  stress,	  in	  both	  pre-­‐	  and	  post-­‐	  MBSR	  training	  (Brown	  &	  Ryan,	  2003).	  In	  a	  controlled	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laboratory	  environment	  fifteen	  minutes	  of	  mindfulness	  practice	  before	  exposure	  to	  stressors	  helped	  practitioners	  regulate	  their	  emotional	  reaction	  to	  those	  stressors.	  In	  this	  study	  mindfulness	  practice	  also	  decreased	  the	  time	  it	  took	  to	  return	  to	  their	  pre-­‐stress	  exposure	  emotional	  state	  before	  stress	  exposure	  (Arch	  &	  Craske,	  2006;	  Broderick,	  2005).	  	  Another	  objective	  measure	  of	  the	  extent	  to	  which	  mindfulness	  buffers	  the	  stress	  response	  is	  the	  stress	  hormone	  concentration.	  	  Brown	  et	  al.	  in	  2012	  wanted	  to	  understand	  how	  mindfulness	  would	  buffer	  one’s	  response	  to	  psychosocial	  stress	  exposure.	  	  To	  do	  this	  they	  grouped	  volunteers	  according	  to	  their	  MAAS	  score,	  and	  measured	  their	  salivary	  cortisol	  levels	  five	  times	  throughout	  ninety	  minutes	  of	  exposure	  to	  psychosocial	  stress	  in	  the	  form	  of	  the	  Trier	  Social	  Stress	  Test	  	  (TSST)	  (Figure	  8;	  Brown	  et	  al.,	  2012).	  	  The	  TSST	  consists	  of	  a	  subject	  delivering	  a	  5-­‐min	  speech	  followed	  by	  a	  series	  of	  simple	  arithmetic	  questions	  in	  front	  a	  two	  peer	  evaluators.	  	  For	  this	  study,	  the	  control	  group	  preformed	  the	  same	  tasks,	  without	  the	  psychosocial	  stress	  associated	  with	  the	  peer	  evaluation.	  They	  found	  that	  higher	  MAAS	  scores	  correlated	  with	  reduced	  cortisol	  response	  curves	  during	  exposure	  to	  stress.	  In	  addition,	  MAAS	  did	  not	  significantly	  reduce	  cortisol	  responses	  in	  the	  control	  group,	  corroborating	  the	  stress-­‐buffering	  theory	  of	  mindfulness	  (Brown	  et	  al.,	  2012).	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  Figure	  9.	  	  Salivary	  cortisol	  concentrations	  status-­‐post	  controlled	  psychosocial	  stress	  exposure.	  	  (A)	  After	  TSST	  administration.	  (B)	  After	  control	  conditions.	  	  The	  grey	  area	  indicates	  administration	  of	  TSST	  or	  control	  condition.	  	  Adapted	  from	  Brown	  et	  al.,	  2012.	  	  While	  the	  objective	  study	  of	  how	  mindfulness	  influences	  our	  reaction	  to	  stress	  is	  still	  in	  its	  infancy,	  there	  is	  evidence	  that	  warrants	  further	  laboratory	  research	  into	  how	  mindfulness	  can	  be	  used	  as	  a	  tool	  to	  help	  mitigate	  the	  harmful	  effects	  of	  psychosocial	  stress.	  Outside	  of	  the	  laboratory,	  there	  have	  been	  an	  abundance	  of	  studies	  documenting	  the	  utility	  of	  mindfulness	  practice	  in	  patients	  exposed	  to	  chronic	  stress.	  	  fMRI	  studies	  of	  MBSR	  practitioners	  showed	  that	  mindfulness	  helps	  patients	  with	  social	  anxiety	  disorder	  to	  regulate	  their	  emotions	  by	  controlling	  emotional	  reactivity	  via	  suppression	  of	  amygdala	  activity.	  (Figure	  10;	  Goldin	  &	  Gross,	  2010).	  Mindfulness	  has	  been	  used	  in	  somatic	  symptom	  disorder,	  a	  mental	  illness	  that	  presents	  with	  physical	  symptoms	  that	  cannot	  be	  explained	  by	  a	  
1.5. Statistical analyses
Analyses of the full repeated cortisol and affect outcomes
were conducted using restricted maximum likelihood mixed
models. Condition and individual difference measures were
tested as main effects and in interaction with each other and
with time (the latter as linear and curvilinear slopes). Parti-
cipant gender, contraceptive use, session day waking time,
session time, and number of previous night sleep hours were
covaried in preliminary analyses. Due to positive skewness,
cortisol values were log-transformed and state PANAS NA
scores were square-root transformed.
2. Results
2.1. Preliminary analyses
We first tested whether the TSST produced significant
changes in cortisol and affective responses, relative to the
control task. Mixed models revealed time2 ! condition inter-
actions on all responses, such that significant curvilinear
change (rise and fall) was observed in cortisol
[F(1,168) = 5.12, p = .03], PANAS NA [F(1,191) = 27.99,
p < .0001], and POMS anxiety [F(1,186) = 31.43, p < .0001]
in the TSST condition only. Thus, the TSST produced signifi-
cant stress-related neuroendocrine and affective responses.
Among the participant covariates, later session times pre-
dicted lower cortisol responses [F(1,41) = 9.31, p = .004] and
males reported higher NA [F(1,63) = 11.90, p = .001] and
anxiety [F(1,62) = 9.77, p = .003]. These covariates were
included in subsequent analyses of the relevant outcomes.
2.2. Primary analyses
The primary analyses examined whether mindfulness mod-
erated the three response curves observed in the TSST
relative to the control condition. In a mixed model predicting
salivary cortisol response, a time2 ! condition ! MAAS mind-
fulness interaction was observed [F(1,166) = 5.12, p = .02],
such that participants higher in mindfulness showed reduced
cortisol responding in the social evaluative TSST condition
(see Fig. 1a); mindfulness was not associated with cortisol
responding in the control TSST condition (Fig. 1b). The same
three-way interaction was observed in the models predicting
NA [F(1,187) = 3.83, p = .05; Fig. 2a and b] and marginally,
anxiety [F(1,182) = 3.66, p = .06; Fig. 2c and d]; higher mind-
fulness predicted lower affective responses.
2.3. Secondary analyses
Among the non-mindfulness dispositional measures and the
baseline affect measures, separate mixed model analyses
showed that only dispositional fear of negative evaluation
predicted cortisol responses [F(1,40) = 4.24, p = .05]; those
with lower scores showed elevated cortisol across conditions.
However, controlling for this variable did not alter the
already reported significant relation between mindfulness
and cortisol responses ( p = .03). In the prediction of psycho-
logical responses, higher perceived stress [F(1,61) = 8.04,
p = .006], trait POMS anxiety [F(1,61) = 5.65, p = .02], and
trait manifest anxiety [F(1,61) = 8.10, p = .006] predicted
higher state anxiety across conditions. In predicting NA
responses over time, only main effects for perceived
stress [F(1,62) = 7.42, p = .008] and manifest anxiety
[F(1,62) = 5.03, p = .03] were found; those with higher trait
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Figure 1 Mean salivary cortisol responses to the Trier Social
Stress Test (a) and the control task (b) according to high and low
mindfulness. Notes. Shaded bars indicate tasks period. MAAS =
Mindful Attention Awareness Scale. MAAS scores were split at the
median for graphical purposes; analyses were conducted using
continuous scores.
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1.5. Statistical analyses
Analyses of the full repeated cortisol and affect outcomes
were conducted using restricted maximum likelihood mixed
models. Condition and individual difference measures were
tested as main effects and in interaction with each other and
with time (the latter as linear and curvilinear slopes). Parti-
cipant gender, contraceptive use, session day waking time,
session time, and number of previous night sleep hours were
covaried in preliminary analyses. Due to positive skewness,
cortisol values were log-transformed and state PANAS NA
scores were square-root transformed.
2. Results
2.1. Preliminary analyses
We first tested whether the TSST produced significant
changes in cortisol and affective responses, relative to the
control task. Mixed models revealed time2 ! condition inter-
actions on all responses, such that significant curvilinear
change (rise and fall) was observed in cortisol
[F(1,168) = 5.12, p = .03], PANAS NA [F(1,191) = 27.99,
p < .0001], and POMS anxiety [F(1,186) = 31.43, p < .0001]
in the TSST condition only. Thus, the TSST produced signifi-
cant stress-related neuroendocrine and affective responses.
Among the participant covariates, later session times pre-
dicted lower cortisol responses [F(1,41) = 9.31, p = .004] and
males reported higher NA [F(1,63) = 11.90, p = .001] and
anxiety [F(1,62) = 9.77, p = .003]. These covariates were
included in subsequent analyses of the relevant outcomes.
2.2. Primary analyses
The primary analyses examined whether mindfulness mod-
erated the three response curves observed in the TSST
relative to the control condition. In a mixed model predicting
salivary cortisol response, a time2 ! condition ! MAAS mind-
fulness interaction was observed [F(1,166) = 5.12, p = .02],
such that participants higher in mindfulness showed reduced
cortisol responding in the social evaluative TSST condition
(see Fig. 1a); mindfulness was not associated with cortisol
responding in the control TSST condition (Fig. 1b). The same
three-way interaction was observed in the models predicting
NA [F(1,187) = 3.83, p = .05; Fig. 2a and b] and marginally,
anxiety [F(1,182) = 3.66, p = .06; Fig. 2c and d]; higher mind-
fulness predicted lower affective responses.
2.3. Secondary analyses
Among the non-mindfulness dispositional measures and the
baseline affect measures, separate mixed model analyses
showed that only dispositional fear of negative evaluation
pre icted cortisol responses [F(1,40) = 4.24, p = .05]; those
ith lower scores showed elevated cortisol across conditions.
However, controlling for this variable did not alter the
already reported significant relation between mindfulness
and cortisol responses ( p = .03). In the prediction of psycho-
logical responses, higher perceived stress [F(1,61) = 8.04,
p = .006], trait POMS anxiety [F(1,61) = 5.65, p = .02], and
trait manifest anxiety [F(1,61) = 8.10, p = .006] predicted
higher state anxiety across conditions. In predicting NA
responses over time, only main effects for perceived
stress [F(1,62) = 7.42, p = .008] and manifest anxiety
[F(1,62) = 5.03, p = .03] were found; those with higher trait
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Figure 1 Mean salivary cortisol responses to the Trier Social
Stress Test (a) and the control task (b) according to high and low
mindfulness. Notes. Shaded bars indicate tasks period. MAAS =
Mindful Attention Awareness Scale. MAAS scores were split at the
median for graphical purposes; analyses were conducted using
continuous scores.
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medical	  condition.	  	  This	  condition	  exposes	  the	  patient	  with	  extreme	  psychosocial	  stress,	  as	  often	  there	  is	  no	  cure	  for	  their	  symptoms.	  Eight	  weeks	  of	  mindfulness	  practice	  helped	  these	  patients	  reduce	  stress,	  gain	  a	  better	  self-­‐image,	  and	  enhance	  their	  social	  functioning	  (Lind	  et	  al.,	  2014).	  	  
	  Figure	  10.	  The	  effect	  of	  MBSR	  on	  blood	  oxygenation	  level-­‐dependent	  contrast	  signal	  in	  the	  right	  dorsal	  amygdala	  of	  patients	  with	  social	  anxiety	  disorder.	  Participants	  in	  this	  study	  underwent	  fMRI	  both	  before	  and	  after	  a	  course	  of	  MBSR.	  During	  imaging,	  they	  were	  told	  to	  react	  to	  a	  negative	  self-­‐belief	  for	  twelve	  seconds,	  followed	  by	  twelve	  seconds	  of	  FA	  meditation.	  	  At	  the	  end	  of	  this	  period	  they	  were	  asked	  to	  rate	  the	  intensity	  of	  their	  negative	  emotions.	  	  As	  signified	  by	  the	  three	  asterisks,	  MBSR	  resulted	  in	  reduced	  amygdala	  activity	  during	  exposure	  to	  self-­‐induced	  psychosocial	  stress.	  Adapted	  from	  Goldin	  &	  Gross,	  2010.	  	   	  In	  cancer	  patient	  populations	  mindfulness	  has	  been	  found	  to	  decrease	  perceptions	  of	  psychosocial	  stress	  stress	  (Speca	  et	  al.,	  2000).	  Objective	  measures	  have	  correlated	  increased	  mindfulness	  through	  MBSR	  with	  decreased	  mood	  disturbance	  and	  stress	  in	  early	  stage	  breast	  and	  prostate	  cancer	  patients.	  Mindfulness	  has	  even	  been	  shown	  to	  reverse	  the	  adverse	  epigenetic	  signature	  of	  stress-­‐related	  psychosocial	  disease	  (Brown	  &	  Ryan,	  2003;	  Saban	  et	  al.,	  2014;	  Zainal	  et	  al.,	  2013).	  
This study examined only breath-focused attention on sensation
at the nostrils. There are many other important mindfulness prac-
tices taught in MBSR that deserve empirical investigation, for
example, the effects of body scan meditation and mere observation
of the changing or transient nature of experience. Thus, results
from this study cannot be generalized to other forms of mindful
attention such as mindful attention of taste, sound, mental states
and other bodily sensations. To begin to specify how MBSR
works, it may be instructive to compar the effects of clinical
interventions with different mechanisms of change (e.g., cognitive
disputation, acceptance, attention training) on the neural bases of
mindful attention.
Future studies will benefit from using a randomized clinical trail
methodology with at least two groups that undergo two types of
stress reduction courses in order to delineate factors that might
contribute to changes in attentional deployment, attention brain
networks, and specificity of changes in clinical symptoms as well
as address other potential confounds such as practice effects and
habituation to the scanner environment. Using experimental para-
digms that present a variety of linguistic and nonlinguistic emo-
tional probes and assess the effectiveness of several types of
emotion regulation strategies may help delineate underlying mech-
anisms in MBSR. Furthermore, future studies should consider
using self-report measures of mindfulness pre-, during, and post-
MSBR to examine change during and post-MBSR compared with
baseline trait mindfulness.
Conducting an analysis of individual differences at baseline to
enhance effective treatment matching to different types of medi-
tation practices (not just mindfulness) and to different combina-
tions or doses of clinical therapies (e.g., pharmacological,
cognitive–behavioral, meditation-based interventions) would be a
major contribution. Finally, understanding how mindfulness prac-
tice in the health care provider interacts with mindfulness practice
of the individual receiving health care is a domain of inquiry that
has not yet been investigated.
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Figure 5. Right dorsal amygdala blood oxygenation level-dependent (BOLD) contrast signal time series during
reacting to negative self-beliefs and breath-focused attention in social phobics (SP) at both pre- and post-
mindfulness-based stress reduction (MBSR). ! p ! .05. Rate " negative emotion rating; React " reacting to the
negative self-belief; Breath-Focus " instruction to focus attention on breath sensation.




















































































Neurological	  networks	  involved	  in	  mindfulness	  	  	   	   In	  their	  2011	  review,	  Holzel	  et	  al.	  described	  five	  neurological	  mechanisms	  through	  which	  mindfulness	  meditation	  may	  meditate	  its	  clinical	  benefits	  (Table	  2;	  Holzel	  et	  al.,	  2011).	  Each	  of	  these	  cognitive	  branches	  of	  mindfulness	  were	  described	  and	  assigned	  to	  a	  particular	  region	  of	  the	  brain.	  	  	   	   Table	  2.	  Psychological	  mechanisms	  and	  neuroanatomy	  of	  mindfulness	  as	  proposed	  by	  Holzel	  et	  al.,	  2012.	  	  
	  	  	  	   The	  last	  ten	  years	  have	  brought	  about	  an	  exponential	  increase	  of	  imaging	  studies	  exploring	  the	  neurological	  mechanisms	  through	  which	  mindfulness	  exerts	  its	  clinical	  effects	  (Chiesa	  &	  Serretti,	  2010;	  Lutz	  et	  al.,	  2009;	  Malinowski,	  2013;	  Marchand,	  2014).	  Utilizing	  functional	  magnetic	  resonance	  imaging	  (fMRI),	  electroencephalographic,	  magnetic	  resonance	  imaging,	  fractional	  anisotropy,	  and	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Components of Mindfulness Meditation
We bel ve that an a ray of distinct b t interacting mechanisms 
are at play in producing the benefits of mindfulness meditation 
practice and propose that the combination of the following 
components—some of which have been identified in previous 




3. Emotion regulation, including
 a. Reappraisal
 b. Exposure, extinction, and reconsolidation
4. Change in perspective on the self
These components interact closely to constitute a process 
of enhanced self-regulation (Carver & Scheier, 2011; Vohs & 
Baumeister, 2004). However, the different components might 
come into play to varying degrees within any specific moment 
during mindfulness meditation. In the following sections, we 
address each of these components individually (see Table 2 for 
a list of the components and their characteristics).
1. Attention regulation
Many meditation traditions emphasize the necessity to culti-
vate attention regulation early in the practice (e.g., samadhi in 
the Theravada Buddhist tradition [Hart, 1987]; samatha in 
Tibetan Buddhist traditions [Lutz, Dunne, & Davidson, 2007]; 
or dharana in Indian Yoga traditions [Vishnu Devananda, 
1999]). They often recommend a focused attention meditation 
before moving on to other types of meditations later in the 
learning process, such as those that focus on cultivating posi-
tive emotions. In focused attention meditation ( HYPERLINK 
"" \l "bib148" \o "bib148" Lutz, Slagter, et al., 2008), attention 
is supposed to rest on a single object. Whenever the practitio-
ner notices that the mind has wandered off, she or he returns it 
to the chose  object. A typic l instruction for a focused atten-
tion meditation in the mindfulness meditation tradition is the 
following: “Focus your entire attention on your incoming and 
outgoing breath. Try to sustain your attention there without 
distraction. If you get distracted, calmly return your attention 
to the breath and start again” (Smith & Novak, 2003; p.77). 
Illustrating the effects of repeated practice of focused attention 
meditation, meditators report that the regular practice enables 
them to focus their attention for an extended period of time 
(Barinaga, 2003), and distractions disturb this focus less fre-
quently during formal meditation practice and in everyday 
life. In accordance with such self-reports, a number of studies 
have empirically documented enhanced attentional perfor-
mance in meditators (e.g., Jha et al., 2007; Slagter et al., 2007; 
Valentine & Sweet, 1999; van den Hurk, Giommi, Gielen, 
Speckens, & Barendregt, 2010).
Behavioral findings on meditation and executive attention. Dur-
ing focused attention meditation, distracting external events as 
Table 2. Components Proposed to Describe the Mechanisms Through Which Mindfulness Works
Mechanism Exemplary instructions
Self-reported and experimental 
behavioral findings Associated brain areas
1. Attention regulation Sustaining attention on the 
chosen object; whenever 
distracted, returning attention 
to the object
Enhanced performance: executive 
attention (Attention Network 
Test and Stroop interference), 
orienting, alerting, diminished 
attentional blink effect
Anterior cingulate cortex
2. Body awareness Focus is usually an object of 
internal experience: sensory 
experiences of breathing, 
emotions, or other body 
sensations
Increased scores on the Observe 
subscale of the Five Facet Mind-
fulness Questionnaire; narrative 




3.1 Emotion regulation:  
reappraisal
Approaching ongoing emotional 
reactions in a different way 
(nonjudgmentally, with ac-
ceptance)
Increases in positive reappraisal 
(Cognitive Emotion Regulation 
Questionnaire)
(Dorsal) prefrontal cortex 
(PFC)
3.2 Emotion regulation: 
exposure, extinction, and 
reconsolidation
Exposing oneself to whatever is 
present in the field of aware-
ness; letting oneself be affected 
by it; refraining from internal 
reactivity
Increases in nonreactivity to inner 




4. Change in perspective on  
the self
Detachment from identification 
with a static sense of self
Self-reported changes in self-con-
cept (Tennessee Self-Concept 
Scale, Temperament and Char-
acter Inventory)
Medial PFC, posterior 
cingulate cortex, insula, 
temporo-parietal 
junction
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gyrification	  we	  can	  better	  evaluate	  the	  neurological	  mechanisms	  of	  mindfulness	  and	  morphological	  changes	  caused	  by	  FA	  and	  OM	  mindfulness	  practice	  (Luders	  et	  al.,	  2012,	  2013;	  Posner	  et	  al.,	  2014).	  Based	  on	  the	  results	  of	  hundreds	  of	  imaging	  studies,	  Marchand	  compiled	  a	  list	  of	  regions	  that	  have	  shown	  morphological	  changes	  after	  mindfulness	  training	  and	  a	  list	  of	  regions	  of	  the	  brain	  activated	  through	  mindfulness	  as	  shown	  in	  tables	  3	  and	  4	  (Marchand,	  2014).	  	  All	  of	  the	  structures	  identified	  by	  Holzel	  et	  al.	  2011	  to	  be	  involved	  in	  the	  neurological	  mechanisms	  of	  mindfulness	  are	  confirmed	  by	  Marchand	  et	  al.’s	  review	  of	  more	  recent	  imaging	  studies.	  Many	  of	  the	  brain	  regions	  discussed	  previously	  involved	  in	  FA	  and	  OM	  meditation	  are	  listed	  in	  this	  tables	  as	  well.	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Table	  3.	  Brain	  regions	  exhibiting	  morphological	  changes	  correlated	  with	  mindfulness	  practice	  from	  Marchand,	  2014.	  Anterior	  cingulate	  cortex	  	  Orbitofrontal	  cortex	  Inferior	  temporal	  gyrus	  Insula	  Lingual	  gyrus	  Cuneus	  Sensorimotor	  cortex	  Fusiform	  gyrus	  Cuneus	  Corpus	  callosum	  Posterior	  cingulate	  cortex	  Cerebellum	  Hippocampus	  Amygdala	  Putamen	  Caudate	  Thalamus	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Table	  4.	  Brain	  regions	  showing	  activation	  during	  mindfulness	  practice	  from	  Marchand,	  2014.	  Frontal	  cortex	  Lateral	  frontal	  cortex	  Ventrolateral	  prefrontal	  cortex	  Dorsolateral	  prefrontal	  cortex	  Medial	  frontal	  cortex	  Anterior	  cingulate	  cortex	  Orbitofrontal	  cortex	  Posterior	  medial	  cortex	  Posterior	  cingulate	  cortex/precuneus	  Ventral	  posteromedial	  cortex	  Insula	  Temporal	  cortex	  Temporoparietal	  junction	  Sensorimotor	  cortex	  Inferior	  parietal	  lobule	  Parahippocampal	  gyrus	  Amygdala	  Basal	  ganglia	  Thalamus	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Clinical	  Benefits	  of	  Mindfulness:	  Relieving	  immunosuppression	  and	  
inflammation	  	   	  It	  is	  well	  established	  that	  therapies	  targeted	  at	  relieving	  stress	  have	  positive	  effects	  on	  immune	  function	  (Miller	  &	  Cohen,	  2001).	  	  Currently,	  the	  main	  evidence	  illustrating	  cognitive	  based	  therapies	  such	  as	  MBSR’s	  ability	  to	  reduce	  inflammation	  is	  a	  reduction	  in	  inflammatory	  markers	  and	  down-­‐regulation	  of	  pro-­‐inflammatory	  gene	  expression.	  Mindfulness	  based	  therapies	  including	  MBSR,	  Qi	  Gong,	  and	  Yoga	  have	  been	  found	  to	  effectively	  reduce	  C-­‐reactive	  protein,	  a	  marker	  of	  chronic	  inflammation	  produced	  by	  the	  liver	  in	  response	  to	  systematic	  inflammation	  (Creswell	  et	  al.,	  2012;	  Malarkey	  et	  al.,	  2013;	  Morgan	  et	  al.,	  2014).	  Seven	  to	  sixteen	  weeks	  of	  mindfulness-­‐based	  therapies	  were	  found	  to	  significantly	  reduce	  levels	  of	  C-­‐reactive	  protein	  (Morgan	  et	  al.,	  2014).	  	  	  In	  addition	  to	  these	  findings,	  a	  study	  administering	  an	  abbreviated	  version	  of	  MBSR	  to	  professionals	  during	  their	  lunch	  hour	  found	  a	  decrease	  in	  C-­‐reactive	  peptide	  during	  treatment,	  and	  at	  2	  and	  6-­‐month	  follow-­‐ups	  (Malarkey	  et	  al.,	  	  2013).	  While	  mindfulness	  practice	  is	  documented	  to	  play	  a	  role	  in	  C-­‐reactive	  protein	  levels,	  no	  current	  literature	  has	  been	  published	  observing	  a	  reduction	  in	  other	  pro-­‐inflammatory	  cytokines	  such	  as	  Il-­‐1,	  Il-­‐6,	  or	  TNF-­‐a.	  	   Utilization	  of	  cognitive	  based	  stress	  management	  techniques	  reverses	  the	  pro-­‐inflammatory	  gene	  expression	  patterns	  found	  in	  leukocytes	  due	  to	  chronic	  stress	  exposure	  (Antoni	  et	  al.,	  2012).	  In	  a	  2012	  study,	  Creswell	  et	  al.	  explored	  how	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mindfulness	  affects	  immune	  cell	  gene	  expression.	  They	  administered	  an	  8-­‐week	  course	  of	  MBSR	  to	  volunteers	  with	  no	  mindfulness	  experience.	  After	  comparing	  pre	  and	  post-­‐treatment	  blood	  samples	  they	  found	  that	  MBSR	  down-­‐regulated	  expression	  of	  NF-­‐kB	  regulated	  pro-­‐inflammatory	  genes	  (Creswell	  et	  al.,	  2012).	  	  A	  2013	  study	  by	  Black	  et	  al.	  studied	  yogic	  meditation	  in	  their	  chronic	  stress	  model	  of	  dementia	  care	  givers.	  They	  found	  that	  twelve	  minutes	  of	  daily	  meditation	  enhanced	  immunoglobulin-­‐related	  mRNA	  expression	  and	  inhibited	  the	  expression	  of	  pro-­‐inflammatory	  mRNA	  transcripts	  including	  NF-­‐kB	  (Black	  et	  al.,	  2013).	  	  Mindfulness’s	  ability	  to	  enhance	  immune	  function	  and	  reduce	  inflammation	  has	  been	  observed	  in	  diverse	  patient	  populations	  exposed	  to	  chronic	  stress.	  Patients	  with	  HIV-­‐1	  have	  used	  a	  course	  of	  MBSR	  to	  significantly	  slow	  CD4+	  T	  lymphocyte	  depletion	  (Creswell	  et	  al.,	  2009).	  	  Mindfulness	  may	  even	  play	  a	  role	  in	  curbing	  immune	  suppression	  experienced	  after	  physical	  stress	  (Solberg	  et	  al.,	  1995).	  Further	  research	  is	  warranted	  to	  better	  understand	  how	  mindfulness	  affects	  inflammatory	  processes	  and	  how	  it	  can	  be	  utilized	  to	  complement	  treatment	  for	  chronic	  inflammatory	  diseases.	  
	   	  
	  38 
Clinical	  benefits	  of	  mindfulness:	  Cellular	  and	  genomic	  alterations	  induced	  by	  
mindfulness	  practice	  	   	  In	  addition	  to	  the	  anti-­‐inflammatory	  gene	  expression	  changes	  discussed	  above,	  mindfulness	  practice	  has	  been	  associated	  with	  reversing	  a	  number	  of	  other	  age-­‐related	  cellular	  processes.	  In	  2013	  Kaliman,	  et	  al.	  compared	  gene	  expression	  of	  mononuclear	  leukocytes	  in	  expert	  and	  novice	  meditators	  (Kaliman	  et	  al.,	  2014).	  	  In	  this	  study	  the	  expert	  group	  averaged	  6,240	  hours	  of	  lifetime	  sitting	  mindfulness	  meditation,	  and	  novices	  had	  no	  previous	  experience	  with	  mindfulness	  practice.	  Both	  groups	  were	  subjected	  to	  an	  intensive	  eight-­‐hour	  mindfulness	  meditation	  intervention,	  while	  controls	  partook	  in	  a	  non-­‐mindfulness	  related	  intentional	  activities.	  The	  mindfulness	  group	  showed	  decreased	  expression	  of	  histone	  deacetylase	  and	  pro-­‐inflammatory	  genes.	  	  In	  addition,	  they	  found	  volunteers	  with	  reduced	  expression	  of	  these	  genes	  to	  have	  a	  better	  cortisol	  recovery	  after	  TSST	  administration	  (Kaliman	  et	  al.,	  2014).	  	  	  In	  a	  similar	  study	  Bhasin	  et	  al.	  studied	  the	  effect	  of	  relaxation	  response	  training	  on	  gene	  expression	  and	  found	  8	  weeks	  of	  training	  led	  to	  enhanced	  expression	  of	  genes	  related	  to	  metabolism,	  mitochondrial	  function,	  insulin	  secretion,	  and	  telomere	  maintenance	  (Bhasin	  et	  al.,	  2013).	  	  In	  addition,	  they	  found	  mindfulness	  to	  down-­‐regulate	  NF-­‐kB	  target	  pro-­‐inflammatory	  genes	  in	  addition	  to	  other	  pathways	  activated	  by	  psychosocial	  stress	  exposure	  (Bhasin	  et	  al.,	  2013;	  Dusek	  et	  al.,	  2008).	  	  One	  of	  the	  most	  harmful	  consequences	  of	  chronic	  stress	  induced	  NF-­‐kB	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activation	  is	  oxidative	  stress.	  This	  oxidative	  stress	  is	  generally	  harmful	  for	  cellular	  health	  and	  contributes	  to	  inflammatory	  processes	  that	  aid	  in	  oncogenesis	  (Reuter	  et	  al.,	  2010).	  Chronic	  inflammation	  produces	  reactive	  oxygen	  species	  (ROS)	  that	  oxidize	  DNA	  and	  increase	  the	  likelihood	  of	  oncogenic	  mutations	  that	  avoid	  DNA	  repair	  mechanisms	  (Federico	  et	  al.,	  2007).	  In	  addition,	  reactive	  oxygen	  species	  can	  disrupt	  proper	  cellular	  physiology	  by	  blocking	  cell-­‐to-­‐cell	  communication	  and	  modifying	  kinase-­‐signaling	  pathways	  (Klaunig	  et	  al.,	  1998).	  	  Regular	  practice	  of	  mindfulness	  has	  been	  shown	  to	  reduce	  lipid	  peroxidation,	  a	  marker	  of	  oxidative	  stress	  (Kim	  et	  al.,	  2005;	  Schneider	  et	  al.,	  1998).	  This	  could	  be	  because	  mindfulness	  practice	  promotes	  the	  up-­‐regulation	  of	  ATP	  synthase,	  critical	  enzymes	  involved	  in	  the	  electron	  transport	  chain	  and	  inhibition	  of	  free-­‐radial	  production.	  	  Mindfulness	  also	  up-­‐regulates	  cytochrome	  P450,	  the	  enzyme	  family	  responsible	  for	  oxidative	  metabolism	  and	  the	  upstream	  regulation	  of	  ROS	  production	  (Bhasin	  et	  al.,	  2013).	  	  Another	  measure	  of	  immune	  cell	  health	  is	  telomere	  length	  and	  telomerase	  activity.	  	  Decreased	  telomeric	  length	  has	  been	  proposed	  to	  be	  part	  of	  the	  pathological	  mechanism	  of	  chronic	  stress	  (Epel	  et	  al.,	  2004).	  Mindfulness	  meditation	  leads	  to	  elevated	  serum	  levels	  of	  dehydroepiandrosterone-­‐sulfate,	  a	  hormone	  known	  to	  exert	  a	  protective	  effect	  over	  telomeres	  (Glaser	  et	  al.,	  1992).	  A	  study	  conducted	  by	  Jacobs	  et	  al	  in	  2011,	  explored	  the	  effect	  of	  intensive	  six-­‐hour	  daily	  mindfulness	  meditation	  for	  three	  months	  on	  telomerase	  activity.	  	  Retreat	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participants	  exhibited	  decreased	  perceived	  psychosocial	  stress	  and	  significantly	  increased	  telomerase	  activity	  as	  shown	  in	  figure	  11	  (Figure	  11;	  Jacobs	  et	  al.,	  2011).	  
	  Figure	  11.	  The	  effect	  of	  an	  intensive	  meditation	  retreat	  on	  telomerase	  activity.	  	  After	  controlling	  for	  age	  and	  body-­‐mass	  index,	  participants	  in	  the	  retreat	  were	  found	  to	  have	  significantly	  increased	  telomerase	  activity	  when	  compared	  with	  the	  control.	  Adapted	  from	  Jacobs	  et	  al.,	  2011.	  	  	  	  Although	  the	  study	  of	  mindfulness’s	  affect	  on	  telomere	  is	  in	  its	  infancy,	  several	  studies	  have	  pointed	  towards	  a	  buffering	  effect	  from	  the	  harmful	  effects	  of	  chronic	  stress	  exposure	  (Hoge	  et	  al.,	  2013;	  Schutte	  &	  Malouff,	  2014).	  There	  is	  significant	  molecular	  evidence	  documenting	  mindfulness’s	  clinical	  benefits.	  	  Further	  studies	  are	  necessary	  to	  understand	  how	  to	  best	  utilize	  mindfulness	  in	  the	  clinic.	  	  	   	  
4.2. Difference of post-retreat telomerase
activity between control and retreat groups
In the control group, one outlier was identified as having a
telomerase value beyond 2.5 standard deviations of the
control group mean and was removed from further analyses.
The control and retreat groups were homogeneous with
respect to error variance [Levene’s test; F(1,38) = 0.53,
p = 0.47)], with normal distributions for the retreat group
(W = 0.94, p = 0.40) and control group (W = 0.94, p = 0.13).
After controlling for age and post-retreat BMI, there was a
significant main effect of retreat group participation
[F(1,36) = 3.01, p < 0.05], with greater telomerase activity
in the retreat participants than in the control group (Fig. 2).
Partial eta squared ðh2pÞ ¼ 0:077, indicating that being
assigned to either the retreat or control group accounted
for 7.7% of the variance. This effect is small, using the
generally accepted benchmarks for effect size (Cohen,
1992). The effects of the covariates — age [F(1,36) = 0.02,
p = 0.90)] and post-retreat BMI [F(1,36) = 0.01, p = 0.92)] —
were not significant.
4.3. Comparison of psychological changes
between groups
Relative to controls, retreat participants reported significantly
greater increases in Mindfulness, Purpose in Life, and Perceived
Control, and a significantly greater decrease in Neuroticism
(Fig. 3). That is, after controlling for age, therewas a significant
Group $ Time interaction affecting Mindfulness [F(1,53) =
16.97, p < 0.0001], Purpose in Life [F(1,55) = 10.54,
p < 0.0001], Perceived Control [F(1,55) = 11.83, p < 0.0001],
and Neuroticism [F(1,55) = 9.07, p < 0.0001]. These interac-
tions were driven by changes in the retreat group, with self-
reported ratings (M% SD) significantly increasing from pre- to
post-retreat on measures of Mindfulness (5.36% 0.69 to
5.85% 0.67; t = &5.30, p < 0.0001), Purpose in Life
(5.59% 0.83 to 5.84% 0.68; t = &2.31, p < 0.05), Perceived
Control (5.32% 1.04 to 5.81% 0.71; t = &3.77, p < 0.0001),
and significantly decreasing on the measure of Neuroticism
(3.26% 1.14 to 2.82% 1.05, t = 2.89, p < 0.001). Pre-retreat
values did not differ between groups for Purpose in Life,
Perceived Control, or Neuroticism, but did differ for Mindful-
ness, with the retreat group being slightly higher than the
controls (Table 3). In contrast to pre-retreat values, post-
retreat group differences were different between groups for
Purpose in Life, Perceived Control, Neuroticism, and the group
difference was more pronounced for Mindfulness (Table 3). The
same pattern was observed in the subsample of participants in
which telomerase was assayed (Table 3).
4.4. Changes in psychological variables mediate
the group difference in telomerase activity
The values reported below were derived using regression-
based mediation analyses procedures. First, regression coef-
ficients were calculated as reported in the path diagrams in
Figs. 4 and 6. Then, point estimates for the indirect
(mediated) paths and their corresponding confidence inter-
vals were quantified as the product of the regression coeffi-
cients (paths a*b), obtained using a bootstrapping procedure,
as reported in the text below.
Changes in Mindfulness did not significantly mediate the
group effect on post-retreat telomerase ( point esti-
mate = 0.71; BCa = &0.55 to 2.39), with the mediated effect
a proportionate 0.34 of the total effect.
Changes in Perceived Control significantly mediated the
group effect on post-retreat telomerase activity (Figs. 4B and
5A). That is, the group effect was significantly reduced (path
c to path c0) after accounting for changes in Perceived Control
( point estimate = 1.56, BCa = 0.24—3.9), which reduced the
group effect to a non-significant relation (t = 0.70, p = 0.25).
A proportionate 0.60 of the total effect (Fig. 4A) was
explained by this indirect mediation. The positive point
estimate indicates that the more a participant’s sense of
perceived control increased, the higher his or her level of
post-retreat telomerase activity.
Similarly, changes inNeuroticism significantlymediated the
groupeffect on telomerase (Figs. 4Cand5B).That is, thegroup
effect was significantly reduced after accounting for changes
in Neuroticism (point estimate = 1.5, BCa = 0.29—3.8), which
reducedthegroupeffect toanon-significant relation (t = 1.53,
p = 0.23). A proportionate 0.57 of the total effect was
explained by indirect effects. The positive point estimate
[()TD$FIG]
Figure 3 Retreat participants showed increases in Mindfulness
and Purpose in Life, along with increased Perceived Control and
decreased Neuroticism. The Group (retreat vs. control) $ Time
(pre- vs. post-retreat) interaction was significant for all mea-
sures (p < 0.0001. Error bars: %1SEM). Note: for purposes of
comparison across variables, this graph reflects values for sub-
jects who completed all four psychological scales (see methods).
[()TD$FIG]
Figure 2 Post-retreat telomerase activity was significantly
greater in the retre t group (p < 0.05, Error b rs: %1SEM).
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DISCUSSION	  	   	  Mindfulness	  presents	  a	  very	  interesting	  prospect	  for	  cancer	  therapeutics	  because	  of	  its	  synergistic	  psychological	  and	  physiological	  effects.	  It	  has	  been	  shown	  to	  improve	  prostate	  and	  breast	  cancer	  patient’s	  quality	  of	  life	  and	  help	  combat	  oncogenic	  chronic	  inflammation	  (Carlson	  et	  al.,	  2004;	  Malarkey	  et	  al.,	  2013).	  OM	  and	  FA	  presents	  patients	  with	  a	  proven	  cognitive	  strategy	  to	  combat	  the	  harmful	  effects	  of	  the	  prolonged	  psychosocial	  stress	  caused	  by	  a	  cancer	  diagnosis.	  	  Eight-­‐week	  MBSR	  programs	  increase	  quality	  of	  life	  metrics,	  and	  objectively	  reduce	  HPA	  axis	  activity	  (Carlson	  et	  al.,	  2004).	  It	  gives	  patients	  the	  tools	  to	  self-­‐manage	  their	  own	  psychosocial	  risk	  factors.	  According	  to	  Chida	  et	  al.,	  psychosocial	  stress	  influences	  the	  development	  and	  progression	  of	  lung,	  breast,	  head	  and	  neck,	  hepatobiliary,	  and	  hematopoietic	  cancers	  (Chida	  et	  al.	  2008).	  	  The	  practice	  of	  mindfulness	  as	  a	  complementary	  cancer	  presents	  a	  proven	  method	  that	  empowers	  patients	  to	  become	  active	  participants	  in	  their	  own	  psychological	  and	  physiological	  health	  during	  cancer	  treatment.	  
	  
Psychological	  benefits	  of	  mindfulness	  as	  a	  complementary	  cancer	  therapy	  
	   Mindfulness’s	  clinical	  efficacy	  in	  treating	  a	  diverse	  range	  of	  psychological	  disorders	  has	  been	  well	  documented.	  	  MBSR	  has	  been	  used	  to	  treat	  various	  conditions	  ranging	  from	  addiction	  to	  bipolar	  disease	  to	  anxiety	  and	  depression	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(Adams	  et	  al.,	  2014;	  Compare	  et	  al.,	  2013;	  Goldin	  &	  Gross,	  2010;	  Stratford	  et	  al.	  2015).	  FA	  and	  OM	  mindfulness	  are	  effectively	  cognitive	  therapies	  used	  to	  prevent	  the	  ruminative	  and	  intrusive	  thoughts	  that	  lead	  to	  unnecessary	  psychosocial	  stress	  exposure	  (Steiner	  et	  al.,	  2014).	  Mindfulness	  practice	  helps	  develop	  a	  perspective	  of	  non-­‐appraisal	  towards	  emotional	  triggers	  (Bishop	  et	  al.,	  2006).	  	  This	  allows	  patients	  to	  effectively	  cope	  with	  the	  inherent	  stress	  of	  a	  cancer	  diagnosis	  with	  reduced	  activation	  of	  their	  native	  stress	  responses.	  	  This	  makes	  them	  less	  emotionally	  sensitive	  to	  stressors	  and	  able	  to	  tolerate	  more	  emphatic	  emotions	  (Ledesma	  &	  Kumano,	  2009).	  	  MBSR	  has	  been	  proven	  to	  decreases	  symptoms	  of	  psychosocial	  stress	  and	  mood	  disturbance	  in	  a	  variety	  of	  different	  cancer	  diagnoses	  with	  sustained	  benefits	  (Carlson	  et	  al.,	  2014).	  A	  2013	  review	  of	  MBSR	  in	  breast	  cancer	  patients	  by	  Zainal	  et	  al.	  found	  mindfulness	  to	  help	  treat	  stress,	  depression,	  and	  anxiety	  (Zainal	  et	  al.,	  2013).	  	  Mind-­‐body	  medicine	  has	  shown	  to	  be	  effective	  in	  treating	  fatigue	  in	  cancer	  patients,	  one	  of	  the	  most	  prevalent	  side	  effects	  of	  treatment	  (Appling	  et	  al.,	  2012).	  Finally,	  mindfulness	  also	  has	  shown	  promise	  as	  a	  cognitive	  therapy	  for	  pain	  management.	  Research	  has	  shown	  the	  experience	  of	  pain	  is	  modulated	  by	  a	  variety	  of	  different	  cognitive	  variables	  (Hatchard	  et	  al.,	  2014;	  Ploghaus	  et	  al.,	  2001).	  	  OM	  practice	  helps	  patients	  reappraise	  painful	  stimuli.	  Reappraisal	  is	  a	  cognitive	  strategy	  through	  which	  one	  reinterprets	  stressful	  stimuli	  as	  positive	  events	  (Hanley	  &	  Garland,	  2014).	  In	  2013,	  Taylor	  et	  al	  preformed	  fMRI	  scans	  on	  thirteen	  experienced	  meditators	  with	  over	  one	  thousand	  hours	  of	  experience.	  Experienced	  meditators	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have	  altered	  medial	  pre-­‐frontal	  cortex	  activity.	  These	  regions	  of	  the	  brain	  house	  the	  default	  mode	  network	  and	  are	  involved	  in	  self-­‐referential	  processing	  and	  emotional	  appraisal	  (Taylor	  et	  al.,	  2013).	  Practicing	  reappraisal	  through	  OM	  meditation	  gives	  the	  practitioner	  the	  mental	  toolbox	  to	  efficiently	  manage	  the	  ruminative	  or	  intrusive	  thoughts	  that	  lead	  to	  unnecessary	  mental	  illness.	  It	  is	  especially	  effective	  at	  treating	  negative	  appraisals	  in	  addition	  to	  the	  intrusive	  and	  ruminative	  thought	  associated	  with	  a	  cancer	  diagnosis	  (Steiner	  et	  al.,	  2014).	  	  	  	  	  A	  course	  of	  MBSR	  helped	  increase	  health-­‐related	  quality	  of	  life	  and	  decrease	  psychological	  distress	  in	  those	  with	  chronic	  pain	  conditions	  (Rosenzweig	  et	  al.,	  2010).	  OM	  meditation	  stimulates	  parasympathetic	  signaling	  which	  alters	  the	  practitioner’s	  perception	  of	  painful	  stimuli	  (Grant,	  2014).	  	  Mindfulness	  has	  proven	  to	  be	  an	  effective	  cognitive	  therapy	  to	  help	  heal	  the	  psychological	  symptoms	  of	  a	  cancer	  diagnosis	  and	  subsequent	  treatment.	  What	  makes	  mindfulness	  an	  intriguing	  complementary	  cancer	  therapy	  is	  the	  compounding	  therapeutic	  effect	  it’s	  psychological	  benefits	  have	  on	  the	  physiology	  of	  cancer	  treatment.	  	  	  	  	  
Physiological	  benefits	  of	  mindfulness	  as	  a	  complementary	  cancer	  therapy	   	  
	   Mindfulness	  helps	  patients	  buffer	  the	  physiological	  impact	  of	  their	  exposure	  to	  the	  chronic	  psychosocial	  stress	  of	  a	  cancer	  diagnosis.	  	  Mindfulness	  reduces	  psychosocial	  stress	  exposure’s	  negative	  impact	  on	  chronic	  low-­‐level	  inflammation	  and	  immune	  dysregulation.	  By	  reducing	  these	  physical	  symptoms	  mindfulness	  is	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able	  to	  enhance	  the	  efficacy	  of	  current	  chemotherapeutic	  and	  radiation	  treatments	  and	  reduce	  the	  risk	  of	  further	  oncogenesis.	  	  In	  addition,	  mindfulness	  helps	  patients	  cope	  with	  many	  of	  the	  side	  effects	  of	  current	  treatment	  options.	  Currently	  there	  are	  clinical	  trials	  being	  conducted	  to	  understand	  mindfulness’s	  impact	  on	  factors	  such	  as	  quality	  of	  life,	  immune	  health,	  and	  management	  of	  side-­‐effects	  during	  chemotherapeutic	  treatment	  (Identification	  Nos.	  NCT00086762,	  NCT02067351)	  	  	  	  	  Exposure	  to	  chronic	  stress	  has	  wide	  sweeping	  effects	  on	  immune	  health.	  	  Chronic	  stress	  causes	  the	  down-­‐regulation	  of	  class-­‐I	  and	  class-­‐II	  MHC	  molecules,	  proteins	  immune	  cells	  use	  to	  recognize	  tumors,	  in	  addition	  to	  down-­‐regulation	  of	  natural	  killer	  cell	  activity	  (Reiche	  et	  al.,	  2004).	  	  Employing	  mindfulness	  to	  help	  buffer	  stress	  could	  produce	  a	  healthier	  immune	  environment	  to	  help	  combat	  metastases	  (Ben-­‐Eliyahu	  et	  al.,	  1991).	  Mindfulness	  practice	  decreases	  C-­‐related	  protein	  levels,	  increases	  virus-­‐specific	  cell	  mediated	  immunity,	  decreases	  pro-­‐inflammatory	  gene	  expression,	  and	  preserves	  mononuclear	  leukocyte	  telomeres	  (Bhasin	  et	  al.,	  2013;	  Jacobs	  et	  al.,	  2011;	  Morgan	  et	  al.,	  2014).	  Mindfulness	  has	  even	  been	  shown	  to	  help	  reduce	  cyotoxic	  DNA	  damage	  after	  radiotherapy	  (Banerjee	  et	  al.,	  2007).	  	  Mindfulness	  induces	  a	  variety	  of	  important	  physiological	  changes	  that	  are	  conducive	  to	  the	  efficacy	  of	  current	  cancer	  therapeutics.	  Chronic	  stress	  induces	  the	  chronic	  inflammation	  and	  oxidative	  stress	  that	  creates	  an	  environment	  conducive	  to	  tumor	  growth.	  According	  to	  Chua	  et	  al.	  systemic	  inflammation	  is	  negatively	  correlated	  with	  treatment	  outcome	  in	  patients	  taking	  docetaxel	  for	  advanced	  cancers	  (Chua	  et	  al.,	  2012).	  	  In	  fact,	  courses	  of	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chemotherapy	  have	  been	  identified	  to	  contribute	  to	  residual	  systematic	  pro-­‐inflammatory	  epigenetic	  changes	  (Smith	  et	  al.,	  2014;	  Torres	  et	  al.,	  2013).	  Shacter	  et	  al.	  reported	  that	  excessive	  oxidative	  stress	  prevents	  four	  separate	  chemotherapeutic	  drugs	  from	  inducing	  apoptosis	  in	  cancer	  cells	  (Shacter	  et	  al.,	  2000).	  Utilizing	  mindfulness’s	  anti-­‐inflammatory	  properties	  may	  help	  reduce	  inflammation	  and	  oxidative	  stress,	  which	  will	  lead	  to	  more	  effective	  chemotherapeutic	  and	  radiation	  treatments.	  	  	  
Conclusions	  
	   Mindfulness	  practice	  can	  be	  utilized	  to	  produce	  positive	  effects	  on	  the	  psychological	  state	  of	  cancer	  patients	  by	  reducing	  chronic	  stress.	  This	  reduction	  in	  psychosocial	  stress	  exposure	  results	  in	  a	  reduction	  of	  HPA	  axis	  activation	  and	  concentration	  of	  stress	  hormones	  in	  circulation.	  The	  physiological	  alterations	  elicited	  by	  mindfulness	  improve	  native	  immune	  anti-­‐cancer	  activity.	  	  In	  addition	  they	  have	  been	  found	  to	  make	  current	  cancer	  treatments	  more	  effective.	  	  These	  attributes	  make	  mindfulness	  a	  prime	  complementary	  therapy	  to	  current	  treatment	  protocols.	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Patrick	  Donan	  Joyce	  Year	  of	  Birth:	  1989	  	  26	  Burnside	  Ave.	  	  Somerville,	  MA	  02144	  (410)-­‐980-­‐1423	  	  
EDUCATION	  
Elon	  University	  08-­‐12’,	  BS	  in	  Biology	  with	  a	  Business	  Management	  Minor	  	  GPA:	  3.19	  	  
Boston	  University	  12-­‐13’,	  PhD	  candidate	  in	  Molecular/Cell	  Biology	  and	  Biochemistry	  GPA:	  3.12	  
Boston	  University	  13’,	  Post-­‐Baccalaureate	  Summer	  Classes	  GPA:	  3.85	  
Boston	  University	  13-­‐15’,	  MS	  in	  Medical	  Sciences	  Candidate	  GPA:	  3.54	  	  
	  
RESEARCH	  EXPERIENCE	  
Graduate	  Student	  in	  Molecular/Cell	  Biology	  and	  Biochemistry:	  Boston	  University,	  
9/12-­‐5/12	  
	  
• Completed	  laboratory	  rotations	  in	  Stem	  Cell	  and	  Synthetic	  Biology	  
• Techniques	  included:	  cell	  culture,	  bacterial	  cloning,	  transformations,	  transfections,	  qPCR,	  gel	  electrophoresis,	  DNA	  Spectrophotometer,	  immunostaining,	  confocal	  microscopy,	  synthetic	  biology	  circuit	  design	  
	  
Laboratory	  Technician:	  Tumor	  Biology,	  Johns	  Hopkins	  Medicine,	  2010-­‐2011(research	  adviser:	  Dr.	  Stephen	  B.	  Baylin).	  	  
• Techniques	  included:	  cell	  culture,	  	  DNA	  isolation,	  Chromatin	  Immunoprecipitation,	  Analysis	  of	  ChIP-­‐seq	  data,	  and	  	  FACS	  sorting	  
• Troubleshooting	  and	  optimizing	  protocols	  	  
• Introduction	  to	  bioinformatic	  techniques	  including	  R	  
Undergraduate	  Research:	  Department	  of	  Biology,	  Elon	  University,	  2010-­‐2012	  (research	  adviser:	  Dr.	  Michael	  Terribilini)	  	  
• Investigation	  into	  epigenetic	  regulation	  of	  pluripotency,	  focusing	  on	  lincRNAs	  
• Emphasis	  on	  bioinformatic	  techniques	  such	  as	  sequence	  alignment,	  genome	  browsers,	  and	  regulatory	  networks	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CLINICAL	  EXPERIENCE	  
Patient	  and	  Family	  Blum	  Resource	  Center:	  Dana	  Farber	  Cancer	  Institute,	  03/13-­‐09/13	  
• Researched	  and	  communicated	  diagnosis-­‐specific	  information	  to	  patients	  
• Provided	  concierge	  services	  to	  those	  utilizing	  the	  Blum	  Center	  
• Lead	  a	  weekly	  Mindfulness-­‐Meditation	  Class	  for	  patients	  and	  employees	  	  
bWell	  Center:	  Boston	  Medical	  Center,	  02/14-­‐05/14	  
• Facilitated	  a	  youth	  jump	  rope	  clinic	  to	  help	  combat	  childhood	  obesity	  
• Provided	  health	  education	  resources	  to	  pediatric	  patients	  and	  their	  guardians	  
• Provided	  concierge	  services	  for	  Boston	  Medical	  Center’s	  Pediatric	  Department	  
ScribeConnect:	  Orthopedic	  Clinic	  Medical	  Scribe,	  06/14-­‐12/14	  
• Accurately	  documented	  patient-­‐physician	  interaction	  in	  the	  clinic’s	  electronic	  medical	  record	  
• Responsible	  for	  appropriate	  coding	  and	  billing	  of	  patient	  visits.	  	  
• Assisted	  with	  greeting,	  rooming,	  and	  communicating	  health	  information	  to	  the	  clinic’s	  patients	  	  
TEACHING	  EXPERIENCE	  
	  
Teaching	  Fellow:	  Bio107/108	  –	  Biology	  Laboratory	  Instructor	  	  	  
• Lead	  bi-­‐weekly	  laboratory	  sections	  
• Responsible	  for	  lecture	  material,	  extracurricular	  tutoring,	  grading	  and	  administrative	  duties.	  
	  
Teaching	  Assistant:	  Biodiversity,	  Elon	  University,	  Spring	  and	  Fall	  2010.	  	  
• Laboratory	  aid,	  along	  with	  grading	  responsibilities	  for	  laboratory	  assignments.	  
Teaching	  Assistant:	  Organic	  Chemistry,	  Elon	  University,	  Fall	  2010.	  
• Lead	  bi-­‐weekly	  recitation,	  administering	  and	  grading	  assignments	  
• Worked	  in	  conjunction	  with	  faculty	  tutoring	  students	  
BIOBUGS	  volunteer:	  Boston	  University,	  Fall	  2012	  
• Organized	  and	  lead	  a	  group	  of	  local	  high	  school	  students	  through	  a	  college	  level	  biology	  lab	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• Covered	  techniques	  including	  PCR,	  DNA	  fingerprinting,	  ECG,	  and	  blood	  typing	  
UNIVERSITY	  SERVICES	  
Treasurer:	  Meditation	  Club,	  Fall	  2011.	  
• Handled	  finances	  along	  with	  facilitating	  weekly	  meetings	  of	  the	  program	  
Member:	  Club	  Ice	  Hockey,	  2008-­‐2012f	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